The Journal of Urology

• 

  Publication Venue For

  • Reply by Authors.  209:751. 2023
  • Nivolumab Plus Docetaxel in Patients With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Results From the Phase II Checkmate 9KD Trial.  209:445-446. 2023
  • Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer..  207:592-600. 2022
  • Longitudinal Trajectories of Clean Intermittent Catheterization Responsibility in Youths with Spina Bifida..  207:192-200. 2022
  • Re: Private Equity Acquisition and Responsiveness to Service-Line Profitability at Short-Term Acute Care Hospitals.  207:1143-1143. 2022
  • Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial..  205:1733-1739. 2021
  • Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.  206:298-307. 2021
  • Re: Active Surveillance of Metastatic Renal Cell Carcinoma: Results from a Prospective Observational Study (MaRCC).  206:1515-1516. 2021
  • Re: Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population with Favorable-Risk Prostate Cancer: A Randomized Trial.  206:1507-1508. 2021
  • The Urinary Microbiome in Postmenopausal Women with Recurrent Urinary Tract Infections.  206:1223-1231. 2021
  • The Role of Opioids and Their Receptors in Urological Malignancy: A Review..  204:1150-1159. 2020
  • Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy..  204:511-517. 2020
  • A Systematic Review of Complications of Minimally Invasive Surgery in the Pediatric Urological Literature.  203:1010-1016. 2020
  • Reply by Authors..  203:127. 2020
  • Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database..  203:120-127. 2020
  • National Variation in Opioid Prescription Fills and Long-Term Use in Opioid Naïve Patients after Urological Surgery..  202:1036-1043. 2019
  • MP10-06 FACTORS INFLUENCING ICU ADMISSION AND ASSOCIATED OUTCOMES IN PATIENTS UNDERGOING RADICAL CYSTECTOMY WITH ENHANCED RECOVERY PATHWAY.  201. 2019
  • PD33-04 STOMA COMPLICATIONS AND QUALITY OF LIFE IN INDIANA POUCH AND APPENDICO-UMBILICOSTOMY URINARY DIVERSIONS.  201. 2019
  • MP01-19 EXPLORING TECHNIQUE OF THE VESICOURETHRAL ANASTOMOSIS IN ROBOTIC-ASSISTED RADICAL PROSTATECTOMY WITH AUTOMATED AND MANUALLY OBSERVED METRICS.  199. 2018
  • MP49-05 STOMA COMPLICATIONS AND QUALITY OF LIFE IN INDIANA POUCH URINARY DIVERSION.  199. 2018
  • MP80-02 LEVERAGING STRUCTURED DATA IN AN ENTERPRISE-WIDE ELECTRONIC HEALTH RECORD TO IDENTIFY RISK FACTORS FOR POSTOPERATIVE URINARY RETENTION.  199. 2018
  • V07-12 TRANSTHORACIC RESECTION OF RETROCRURAL RECURRENCE IN RENAL CELL CARCINOMA.  199. 2018
  • Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group..  199:713-718. 2018
  • Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance..  199:438-444. 2018
  • Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE..  199:536-542. 2018
  • Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer..  198:1309-1315. 2017
  • Home Urodynamic Pressures and Volume Measurement for the Neurogenic Bladder: Initial Validation Study..  198:1424-1429. 2017
  • The Use of Prostate Specific Antigen Screening in Purchased versus Direct Care Settings: Data from the TRICARE (R) Military Database EDITORIAL COMMENT.  198:1301-1301. 2017
  • Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE..  198:650-656. 2017
  • Re: Examining Penile Sensitivity in Neonatally Circumcised and Intact Men Using Quantitative Sensory Testing.  196:1822-1823. 2016
  • Factors Affecting Quality of Life at Different Intervals After Treatment of Localized Prostate Cancer: Unique Influence of Treatment Decision Making Satisfaction, Personality and Sexual Functioning..  196:1422-1428. 2016
  • The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study..  196:715-720. 2016
  • MP25-15 INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER SYMPTOMS AMONG MEDICARE BENEFICIARIES.  195. 2016
  • MP25-16 MEDICATION SWITCHING AFTER INITIAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER.  195. 2016
  • Predicting the Risk of Breakthrough Urinary Tract Infections: Primary Vesicoureteral Reflux..  194:1396-1401. 2015
  • Does Obesity Modify the Ability of Prebiopsy Prostate Specific Antigen to Detect Prostate Cancer on Repeat Biopsy? Results from the REDUCE Study..  194:52-57. 2015
  • Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database..  193:1232-1238. 2015
  • Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection..  193:1101-1107. 2015
  • Is the appearance of the dextranomer/hyaluronic acid mound predictive of reflux resolution?.  189:1882-1885. 2013
  • Cross-talk and sensitization of bladder afferent nerves.  186:615. 2011
  • Randomized controlled, multicentre clinical trial comparing a dual-probe ultrasonic lithotrite with a single-probe lithotrite for percutaneous nephrolithotomy.  186:919-920. 2011
  • Poor functional status is an independent predictor of surgical site infections due to methicillin-resistant staphylococcus aureus in older adults.  184:1366. 2010
  • 2111 IN VITRO ASSESSMENT OF FRAGMENTATION AND RETROPULSION IN A NEW PNEUMATIC LITHOTRIPSY DEVICE.  183. 2010
  • 889 EFFECT OF EXERCISE ON ERECTILE FUNCTION AFTER BILATERAL NERVE CRUSH INJURY IN A RAT MODEL.  183. 2010
  • DO LAPAROSCOPIC VR SIMULATORS DEMONSTRATE CONVERGENT VALIDITY?.  183:E518-E518. 2010
  • Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model..  183:1619-1624. 2010
  • The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: The colpopexy and urinary reduction efforts (CARE) randomized surgical trial.  184:1421. 2010
  • Editorial Comment.  182:105. 2009
  • Intraurethral stimulation evokes bladder responses via 2 distinct reflex pathways..  182:366-373. 2009
  • A NO CARBOHYDRATE DIET SIGNIFICANTLY PROLONGS SURVIVAL IN A PROSTATE CANCER XENOGRAFT MODEL VIA IGF-1 AND GLOBAL GENE EXPRESSION CHANGES.  181:47-47. 2009
  • Cockcroft-Gault Versus Modification of Diet in Renal Disease: Importance of Glomerular Filtration Rate Formula for Classification of Chronic Kidney Disease in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Editorial Comment.  181:1813-1814. 2009
  • DELAYED PSA RECURRENCE AFTER RADICAL PROSTATECTOMY: HOW TO IDENTIFY PATIENTS AT RISK AND THEIR CLINICAL OUTCOMES?.  181:457-457. 2009
  • Editorial Comment.  181:1671. 2009
  • OUTCOMES AND RESTORATION OF SEXUAL FUNCTION IN ADULT PATIENTS WITH BURIED PENIS.  181:447-448. 2009
  • PATIENT SATISFACTION WITH OBSERVATION OR HORMONAL THERAPY AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) AFTER BIOCHEMICAL FAILURE IN MEN WITH PROSTATE CANCER: RESULTS FROM THE COMPARE REGISTRY.  181:90-90. 2009
  • PERINEAL RADICAL PROSTATECTOMY: WHAT ARE THE TEN YEAR OUTCOMES?.  181:210-210. 2009
  • PREDICTING NON-ORGAN CONFINED PROSTATE CANCER AFTER THE YEAR 2000.  181:609-609. 2009
  • RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH.  181:259-259. 2009
  • SAY NO TO THE US PREVENTATIVE TASK FORCE RECOMMENDATION TO NO LONGER OFFER PROSTATE CANCER SCREENING AFTER AGE 75?.  181:797-797. 2009
  • SCROTAL REDUCTION AND PHALLOPLASTY FOR GENITAL MANIFESTATIONS OF KIPPEL-TRENAUNAY SYNDROME.  181:554-554. 2009
  • The Influence of Statin Medications on Prostate-Specific Antigen Levels.  181:1689-1690. 2009
  • WHO DOES NOT NEED FOLLOW UP TWO YEARS AFTER PROSTATECTOMY? AN ANALYSIS OF 1739 PATIENTS AT DUKE UNIVERSITY MEDICAL CENTER.  181:759-759. 2009
  • Oxalobacter formigenes May Reduce the Risk of Calcium Oxalate Kidney Stones.  181:676-676. 2009
  • Satisfaction and Regret After Open Retropubic or Robot-Assisted Laparoscopic Radical Prostatectomy.  181:635-636. 2009
  • Diabetic urethropathy compounds the effects of diabetic cystopathy..  178:2213-2219. 2007
  • Sunitinib efficacy against advanced renal cell carcinoma..  178:1883-1887. 2007
  • Does preoperative topical antimicrobial scrub reduce positive surgical site culture rates in men undergoing artificial urinary sphincter placement?.  178:1328-1332. 2007
  • Histopathological changes associated with dextranomer/hyaluronic acid injection for pediatric vesicoureteral reflux..  178:1707-1710. 2007
  • Levels of evidence in the urological literature..  178:1429-1433. 2007
  • Long-term continence outcomes after immediate repair of pediatric bladder neck lacerations extending into the urethra..  178:1816-1818. 2007
  • Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection..  178:1702-1705. 2007
  • Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database..  178:1249-1252. 2007
  • Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited..  178:1157-1163. 2007
  • Traumatic obliterative urethral strictures in pediatric patients: failure of the cut to light technique at long-term followup..  178:1656-1658. 2007
  • Urachal anomalies: a longitudinal study of urachal remnants in children and adults..  178:1615-1618. 2007
  • A comparison of the Bricker versus Wallace ureteroileal anastomosis in patients undergoing urinary diversion for bladder cancer..  178:945-948. 2007
  • Complications of laparoscopic surgery for urological cancer: a single institution analysis..  178:786-791. 2007
  • Evidence based clinical practice: a primer for urologists..  178:775-782. 2007
  • Incidence and risk factors of stomal complications in patients undergoing cystectomy with ileal conduit urinary diversion for bladder cancer..  178:950-954. 2007
  • Subcutaneous bupivacaine infiltration and postoperative pain perception after percutaneous nephrolithotomy..  178:925-928. 2007
  • The effect of bulbar urethroplasty on erectile function..  178:1009-1011. 2007
  • Erectile function outcome reporting after clinically localized prostate cancer treatment..  178:597-601. 2007
  • Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis..  178:140-143. 2007
  • Effect of 5-hydroxytryptamine1 serotonin receptor agonists on noxiously stimulated micturition in cats with chronic spinal cord injury..  177:2381-2385. 2007
  • Guideline for the management of clinically localized prostate cancer: 2007 update..  177:2106-2131. 2007
  • Prostate specific antigen recurrence after definitive therapy..  177:1985-1991. 2007
  • Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy..  177:1785-1788. 2007
  • The expression and function of androgen receptor coactivator p44 and protein arginine methyltransferase 5 in the developing testis and testicular tumors..  177:1918-1922. 2007
  • The effect of frequency doubled double pulse Nd:YAG laser fiber proximity to the target stone on transient cavitation and acoustic emission..  177:1542-1545. 2007
  • The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy..  177:1318-1323. 2007
  • A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature..  177:1090-1094. 2007
  • Changing gender prevalence of stone disease..  177:979-982. 2007
  • Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening..  177:499-503. 2007
  • Comparative analysis of urinary incontinence severity after autologous fascia pubovaginal sling, pubovaginal sling and tension-free vaginal tape..  177:604-608. 2007
  • Highlights from the combined Society of Urodynamics and Female Urology, and International Society of Pelvic Neuromodulation annual meeting..  177:691-695. 2007
  • Relationship between body mass index and prostate cancer screening in the United States..  177:493-498. 2007
  • The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B Trials..  177:531-534. 2007
  • Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes..  177:540-545. 2007
  • Bladder diary volume per void measurements in detrusor overactivity..  176:2530-2534. 2006
  • Editorial Comment.  176:2442. 2006
  • Interpreting statistics in the urological literature..  176:1938-1945. 2006
  • Persistent motile sperm after ligation band vasectomy..  176:2146-2148. 2006
  • Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer..  176:1593-1595. 2006
  • Tunneled tunica vaginalis flap is an effective technique for recurrent urethrocutaneous fistulas following tubularized incised plate urethroplasty..  176:1578-1580. 2006
  • Evidence-based medicine: a survey of American Urological Association members..  176:1127-1134. 2006
  • Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men..  176:1108-1113. 2006
  • Prostate specific antigen testing in men older than 75 years in the United States..  176:511-514. 2006
  • Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies..  176:81-86. 2006
  • Outcomes following erosions of the artificial urinary sphincter..  175:2186-2190. 2006
  • Single center experience with endoscopic management of vesicoureteral reflux in children..  175:1889-1892. 2006
  • Closed loop electrical control of urinary continence..  175:1559-1563. 2006
  • Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia..  175:1023-1027. 2006
  • Local cost structures and the economics of robot assisted radical prostatectomy..  174:2323-2329. 2005
  • Clinical research and statistical methods in the urology literature..  174:1374-1379. 2005
  • Novel delivery of oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy model..  174:1133-1136. 2005
  • Passive dilation by ureteral stenting before ureteroscopy: Eliminating the need for active dilation. Editorial comment.  174:1080. 2005
  • Radical perineal prostatectomy for the treatment of localized prostate cancer in morbidly obese patients..  174:131-134. 2005
  • Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations..  173:1991-2000. 2005
  • Ethnic background has minimal impact on the etiology of nephrolithiasis..  173:2001-2004. 2005
  • Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less..  173:2005-2009. 2005
  • Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model..  173:2160-2165. 2005
  • Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro..  173:1552-1556. 2005
  • In vitro comparison of stone retropulsion and fragmentation of the frequency doubled, double pulse nd:yag laser and the holmium:yag laser..  173:1797-1800. 2005
  • Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer..  173:1572-1576. 2005
  • Anastomotic contracture and incontinence after radical prostatectomy: a graded approach to management..  173:1143-1146. 2005
  • Outcomes following revisions and secondary implantation of the artificial urinary sphincter..  173:1242-1245. 2005
  • EDITORIAL COMMENT.  173:750-751. 2005
  • Time to development of symptomatic urinary calculi in a high risk environment..  173:858-861. 2005
  • Editorial comment.  173:119. 2005
  • The effect of botulinum-A toxin on patients with severe urge urinary incontinence..  172:2316-2320. 2004
  • Innovations in shock wave lithotripsy technology: updates in experimental studies..  172:1892-1898. 2004
  • Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy..  172:S42-S46. 2004
  • Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter..  172:1271-1275. 2004
  • Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers..  172:1140-1144. 2004
  • In vitro comparison of fragmentation efficiency of flexible pneumatic lithotripsy using 2 flexible ureteroscopes..  172:967-970. 2004
  • Effects of alpha 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction..  172:758-762. 2004
  • Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring..  172:286-289. 2004
  • Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients..  172:159-163. 2004
  • The effect of treatment strategy on stone comminution efficiency in shock wave lithotripsy..  172:349-354. 2004
  • Internet based multi-institutional clinical research: a convenient and secure option..  171:1880-1885. 2004
  • The use of chemical treatments for improved comminution of artificial stones..  171:1797-1801. 2004
  • Urethral dysfunction in diabetic rats..  171:1959-1964. 2004
  • Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer..  171:1537-1542. 2004
  • Racial/ethnic disparities in the treatment of localized/regional prostate cancer..  171:1504-1507. 2004
  • Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy..  171:1141-1147. 2004
  • Watchful waiting and factors predictive of secondary treatment of localized prostate cancer..  171:1111-1116. 2004
  • Ex vivo ureteroscopic treatment of calculi in donor kidneys at renal transplantation.  171:58-60. 2004
  • Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat..  171:472-477. 2004
  • Pigment epithelium-derived factor, a human testis epididymis secretory product, promotes human prostate stromal cell growth in culture..  171:434-438. 2004
  • The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversal..  171:304-306. 2004
  • Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes..  171:483-489. 2004
  • Evaluation of synchronous twin pulse technique for shock wave lithotripsy: determination of optimal parameters for in vitro stone fragmentation..  170:2190-2194. 2003
  • Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma..  170:2209-2216. 2003
  • Urinary continence and quality of life in the first year after radical perineal prostatectomy..  170:2374-2378. 2003
  • Determining the incidence of horseshoe kidney from radiographic data at a single institution..  170:1722-1726. 2003
  • Perineal repair of pelvic fracture urethral distraction defects: experience in 120 patients during the last 10 years..  170:1877-1880. 2003
  • Routine nasogastric tubes are not required following cystectomy with urinary diversion: a comparative analysis of 430 patients..  170:1888-1891. 2003
  • Evaluating the Accreditation Council on Graduate Medical Education core clinical competencies: techniques and feasibility in a urology training program..  170:1312-1317. 2003
  • In vivo regulation of hTERT expression and telomerase activity by androgen..  170:615-618. 2003
  • A catheter based method to activate urethral sensory nerve fibers..  170:126-129. 2003
  • Identifying patients who are suitable for stentless ureteroscopy following treatment of urolithiasis..  170:103-106. 2003
  • Percutaneous management of calculi within horseshoe kidneys..  170:48-51. 2003
  • Retrograde ureteroscopy in patients with orthotopic ileal neobladder urinary diversion..  170:107-110. 2003
  • Simple perineal prostatectomy: Lessons learned from a modern series. Editorial comment.  170:118. 2003
  • Urethral erosion after synthetic and nonsynthetic pubovaginal slings: differences in management and continence outcome..  170:134-137. 2003
  • A longitudinal assessment of bowel related symptoms and fecal incontinence following radical perineal prostatectomy..  169:2220-2224. 2003
  • Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling..  169:2234-2237. 2003
  • Anatomical correction of vaginal vault prolapse by uterosacral ligament fixation in women who also require a pubovaginal sling..  169:1770-1774. 2003
  • Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy..  169:1670-1675. 2003
  • Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial..  169:1682-1688. 2003
  • Clinical efficacy of a combination pneumatic and ultrasonic lithotrite..  169:1247-1249. 2003
  • Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction..  169:1526-1529. 2003
  • Management of retained retractor during radical perineal prostatectomy..  169:1085. 2003
  • Ureteral access sheath facilitates inspection of incision of ureteropelvic junction..  169:1070-1073. 2003
  • Durability of the medical management of cystinuria..  169:68-70. 2003
  • Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer..  168:2439-2443. 2002
  • Editorial comments.  168:2057-2058. 2002
  • Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats..  168:2269-2274. 2002
  • Laparoscopic hand assisted radical cystectomy with ileal conduit urinary diversion..  168:2103-2105. 2002
  • Priapism associated with hemoglobin C trait..  168:2122. 2002
  • Screening for prostate cancer in high risk populations..  168:1980-1983. 2002
  • Optimal timing of initial postnatal ultrasonography in newborns with prenatal hydronephrosis..  168:1826-1829. 2002
  • Urinary calculi in aviation pilots: what is the best therapeutic approach?.  168:1341-1343. 2002
  • Acute urinary retention associated with the use of cyclooxygenase-2 inhibitors..  168:1106. 2002
  • Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia..  168:1259-1264. 2002
  • Long-term results of Ingelman-Sundberg denervation procedure for urge incontinence refractory to medical therapy..  168:1044-1047. 2002
  • Evaluation of a dissolvable ureteral drainage stent in a Swine model..  168:808-812. 2002
  • Rapidly progressing adenocarcinoma of the prostate presenting as prostatitis..  168:638-639. 2002
  • Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses..  168:442-445. 2002
  • Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer..  168:273-280. 2002
  • Routine postoperative imaging is important after ureteroscopic stone manipulation..  168:46-50. 2002
  • Ureteroscopic treatment of lower pole calculi: comparison of lithotripsy in situ and after displacement..  168:43-45. 2002
  • Passive biaxial mechanical properties of the rat bladder wall after spinal cord injury..  167:2247-2252. 2002
  • Transcorporal artificial urinary sphincter cuff placement in cases requiring revision for erosion and urethral atrophy..  167:2075-2078. 2002
  • Early onset prostate cancer: predictors of clinical grade..  167:1659-1663. 2002
  • Re: Complications of ureteroscopy: analysis of predictive factors..  167:1801-1802. 2002
  • Ureteroscopy for the treatment of urolithiasis in children..  167:1813-. 2002
  • Nitinol stone retrieval-assisted ureteroscopic management of lower pole renal calculi..  167:798-799. 2002
  • In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system: the renoprotective action of allopurinol..  167:327-334. 2002
  • Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy..  166:2198-2201. 2001
  • Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results..  166:2072-2080. 2001
  • The prevalence of testicular microlithiasis in an asymptomatic population of men 18 to 35 years old..  166:2061-2064. 2001
  • Collagen implant for treating stress urinary incontinence in women with urethral hypermobility..  166:1354-1357. 2001
  • Critical analysis of supracostal access for percutaneous renal surgery..  166:1242-1246. 2001
  • Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases..  166:1322-1327. 2001
  • Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men..  166:1328-1331. 2001
  • Revision rate after artificial urinary sphincter implantation for incontinence after radical prostatectomy: actuarial analysis..  166:1372-1375. 2001
  • Genitourinary complications of sickle cell disease..  166:803-811. 2001
  • Prostatic sarcoma with rapid tumor progression after nerve sparing radical cystoprostatectomy..  166:994. 2001
  • Complications of ureteroscopy: analysis of predictive factors..  166:538-540. 2001
  • Inhibition of telomerase is related to the life span and tumorigenicity of human prostate cancer cells..  166:694-698. 2001
  • THE NATURAL PROGRESSION OF ADENOCARCINOMA OF THE EPIDIDYMIS.  608-610. 2001
  • The natural progression of adenocarcinoma of the epididymis..  166:608-610. 2001
  • Interexaminer reliability of transrectal ultrasound for estimating prostate volume..  166:125-129. 2001
  • Simplified ureteral stent placement with the assistance of a ureteral access sheath..  166:206-208. 2001
  • EDITORIAL COMMENT.  165:1525-1525. 2001
  • Positron emission tomography detection of metastatic penile squamous cell carcinoma..  165:1633-1634. 2001
  • The augmented anastomotic urethroplasty: indications and outcome in 29 patients..  165:1496-1501. 2001
  • The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness..  165:1521-1525. 2001
  • Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction..  165:1107-1110. 2001
  • Multimodal therapy for stage IV adult Wilms tumor..  165:1202. 2001
  • Transitional cell carcinoma in a prostatic remnant 10 years after radical cystectomy..  165:1222. 2001
  • Does a ureteral access sheath facilitate ureteroscopy?.  165:789-793. 2001
  • The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor..  165:975-979. 2001
  • The development of erectile dysfunction in men treated for prostate cancer..  165:430-435. 2001
  • Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence..  165:271-276. 2001
  • Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database..  164:1964-1967. 2000
  • HIV infection presenting as an unusually large pure yolk sac tumor of the testis..  164:1653-1654. 2000
  • Quantification of the tip movement of lithotripsy flexible pneumatic probes..  164:1735-1739. 2000
  • GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?.  1121-1136. 2000
  • Gene therapy for prostate cancer: where are we now?.  164:1121-1136. 2000
  • Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy..  164:749-753. 2000
  • Long-term efficacy of simple behavioral therapy for daytime wetting in children..  164:786-790. 2000
  • Acoustic and mechanical properties of artificial stones in comparison to natural kidney stones..  164:537-544. 2000
  • Nephrolithiasis associated with the ketogenic diet..  164:464-466. 2000
  • RE: INCORPORATION OF PATIENT PREFERENCES IN THE TREATMENT OF UPPER URINARY TRACT CALCULI: A DECISION ANALYTICAL VIEW.  164:460-460. 2000
  • Re: Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view..  164:460. 2000
  • Variations in strategy for the treatment of urethral obstruction after a pubovaginal sling procedure..  164:434-437. 2000
  • Clinical efficacy of combined lithoclast and lithovac stone removal during ureteroscopy..  164:40-42. 2000
  • Bladder endometriosis: conservative management..  163:1814-1817. 2000
  • Prostate specific antigen only progression of prostate cancer..  163:1632-1642. 2000
  • Removal of the entrapped basketed ureteral calculus: a novel technique..  163:1863. 2000
  • Use of a working channel catheter during flexible ureteroscopic laser lithotripsy..  163:1808-1809. 2000
  • Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer..  163:972-979. 2000
  • Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy..  163:858-864. 2000
  • Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder..  163:993-998. 2000
  • Re: The significance of the open bladder neck associated with pelvic fracture urethral distraction defects..  163:552. 2000
  • C-CAM adhesion in mouse model (vol 162, pg 892, 1999).  163:253-253. 2000
  • Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy.  164:749-753. 2000
  • Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women..  163:212-214. 2000
  • Erratum: C-CAM adhesion in mouse model (Journal of Urology 162:3 (892)).  163:253. 2000
  • Extra-adrenal pheochromocytoma: a cause of ureteral obstruction..  163:264. 2000
  • Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen..  163:131-136. 2000
  • Long-term efficacy of simple behavioral therapy for daytime wetting in children.  164:786-790. 2000
  • Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis..  162:2211-2216. 1999
  • Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view..  162:1913-1918. 1999
  • p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy..  162:2040-2045. 1999
  • The incidence of nephrolithiasis in patients with spinal neural tube defects..  162:1238-1242. 1999
  • Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer..  162:403-406. 1999
  • Prostate specific antigen: a decade of discovery--what we have learned and where we are going..  162:293-306. 1999
  • Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients..  162:394-397. 1999
  • The significance of the open bladder neck associated with pelvic fracture urethral distraction defects..  162:347-351. 1999
  • Re: Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position..  162:171. 1999
  • Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability..  162:204-212. 1999
  • Do urinary symptoms correlate with urodynamic findings?.  161:1871-1874. 1999
  • Long-term outcome of incontinent ileovesicostomy management of severe lower urinary tract dysfunction..  161:1803-1806. 1999
  • Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction..  161:1070-1076. 1999
  • Extraosseous metaplasia of the renal pelvis in a child..  161:1295-1296. 1999
  • INCORPORATION OF PATIENT PREFERENCES IN THE TREATMENT OF UPPER URINARY TRACT CALCULI.  380-380. 1999
  • Dorsal onlay graft urethroplasty for repair of bulbar urethral stricture..  161:815-818. 1999
  • RE: OUTCOME BASED COMPARISON OF SURGICAL APPROACHES FOR PEDIATRIC PYELOPLASTY.  161:923-923. 1999
  • RE: UNENHANCED HELICAL COMPUTERIZED TOMOGRAPHY FOR THE EVALUATION OF PATIENTS WITH ACUTE FLANK PAIN.  161:926-926. 1999
  • Bladder neck competency at rest in women with incontinence..  161:578-580. 1999
  • Functional anatomy of the male feline urethra: morphological and physiological correlations..  161:654-659. 1999
  • Analysis of homeobox gene HOXA10 mutations in cryptorchidism..  161:275-280. 1999
  • Radical perineal prostatectomy: oncological outcome during a 20-year period..  161:163-168. 1999
  • Lipopolysaccharide upregulates bradykinin 1 receptors in the isolated mouse bladder..  160:2267-2273. 1998
  • Management of female genitourinary fistulas: transvesical or transvaginal approach?.  160:1995-1999. 1998
  • Expeditious method of difficult ureteral stent change with preservation of ureteral access..  160:1781-1783. 1998
  • Re: Osteoporosis after orchiectomy for prostate cancer..  160:1809. 1998
  • Transient lower extremity neurapraxia associated with radical perineal prostatectomy: a complication of the exaggerated lithotomy position..  160:1376-1378. 1998
  • Androgen receptor gene alterations are not associated with isolated cryptorchidism..  160:863-865. 1998
  • Pubovaginal sling using cadaveric allograft fascia for the treatment of intrinsic sphincter deficiency..  160:759-762. 1998
  • Transvaginal repair of vesicovaginal fistulas after hysterectomy by vaginal cuff excision..  160:728-730. 1998
  • Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain..  160:679-684. 1998
  • CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy..  160:459-465. 1998
  • Laparoscopic ureteroureterostomy for retrocaval ureter..  160:121-122. 1998
  • Laser treatment of large cavernous hemangiomas of the penis..  160:60-62. 1998
  • Re: Treatment results using pubovaginal slings in patients with large cystoceles and stress incontinence..  160:132-134. 1998
  • Endourological management of a large distal ureteral calculus in a patient with ureterosigmoidostomy diversion..  159:2081-2082. 1998
  • Outcome based comparison of surgical approaches for pediatric pyeloplasty: dorsal lumbar versus flank incision..  159:2116-2119. 1998
  • Variations in Valsalva leak point pressure with increasing vesical volume..  159:1909-1911. 1998
  • Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors..  159:1725-1730. 1998
  • Outcomes of varicocele ligation done for pain..  159:1565-1567. 1998
  • Current concepts in the biology and management of Wilms tumor..  159:1316-1325. 1998
  • Our experience with pubovaginal slings in patients with stress urinary incontinence..  159:1195-1198. 1998
  • Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery..  159:1199-1201. 1998
  • Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer..  159:929-933. 1998
  • The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases..  159:935-940. 1998
  • The incidence of Helicobacter pylori in patients with interstitial cystitis..  159:772-773. 1998
  • Metastatic Crohn's disease involving penile skin..  159:506-507. 1998
  • A followup on transurethral collagen injection therapy for urinary incontinence..  159:106-108. 1998
  • Pubovaginal sling using cadaveric allograft fascia for the treatment of intrinsic sphincter deficiency.  160:759-762. 1998
  • Transvaginal repair of vesicovaginal fistulas after hysterectomy by vaginal cuff excision.  160:728-730. 1998
  • Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain.  160:679-684. 1998
  • Controlled, forced collapse of cavitation bubbles for improved stone fragmentation during shock wave lithotripsy..  158:2323-2328. 1997
  • Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?.  158:2123-2126. 1997
  • Splenosis presenting as a mass on digital rectal examination..  158:2244. 1997
  • Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer..  158:2245-2246. 1997
  • Polypoid arteriovenous malformation of the ureter..  158:1903-1904. 1997
  • Congenital mesoblastic nephroma in a child with the Beckwith-Wiedemann syndrome..  158:1532-1533. 1997
  • A renal size nomogram for the patient with myelomeningocele..  158:1265-1267. 1997
  • Comparison of onlay and tubularized island flaps of inner preputial skin for the repair of proximal hypospadias..  158:1172-1174. 1997
  • Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors..  158:620-625. 1997
  • Treatment results using pubovaginal slings in patients with large cystoceles and stress incontinence..  158:431-434. 1997
  • Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children..  157:1846-1851. 1997
  • Gossypiboma (retained surgical sponge) and recurrent bladder neck contracture after radical retropubic prostatectomy and bilateral pelvic lymph node dissection..  157:1356-1357. 1997
  • Molecular biology and function of the androgen receptor in genital development..  157:1377-1386. 1997
  • Voiding dysfunction following incontinence surgery: diagnosis and treatment with retropubic or vaginal urethrolysis..  157:821-823. 1997
  • Retrograde treatment of ureteropelvic junction obstruction using the ureteral cutting balloon catheter..  157:454-458. 1997
  • Water intoxication in a patient with the Prader-Willi syndrome treated with desmopressin for nocturnal enuresis..  157:646-647. 1997
  • Endoscopy and dilation of urethral defects and strictures..  157:102-103. 1997
  • Favorable outcome of pubovaginal slings for geriatric women with stress incontinence..  157:125-128. 1997
  • Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathological stage?.  157:214-218. 1997
  • Reply: Re modified ingelman-sundberg bladder denervation procedure for intractable urge incontinence.  158:888. 1997
  • The influence of ejaculation on serum levels of prostate specific antigen..  157:209-211. 1997
  • The role of retroperitoneal lymphadenectomy in mature teratoma of the testis..  157:160-163. 1997
  • Treatment of complex anterior urethral stricture disease with mesh graft urethroplasty..  157:104-108. 1997
  • Renal ultrasound changes after pyeloplasty in children with ureteropelvic junction obstruction: long-term outcome in 47 renal units..  156:2020-2024. 1996
  • Modified Ingelman-Sundberg bladder denervation procedure for intractable urge incontinence..  156:1744-1747. 1996
  • Wear particles in bilateral internal iliac lymph nodes after loosening of a painless unilateral cemented total hip arthroplasty..  156:1775-1776. 1996
  • Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer..  156:1511-1516. 1996
  • Enteric type adenocarcinoma of the upper tract urothelium associated with ectopic ureter and renal dysplasia: an oncological rationale for complete extirpation of this aberrant developmental anomaly..  156:1272-1274. 1996
  • Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy..  156:1064-1068. 1996
  • Androgen receptor gene mutations are rarely associated with isolated penile hypospadias..  156:828-831. 1996
  • Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival..  156:450-453. 1996
  • Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate cancer: the relationship between nadir level and disease-free survival..  156:450-453. 1996
  • Reappraisal of the role of human chorionic gonadotropin in the diagnosis and treatment of the nonpalpable testis: a 10-year experience..  156:804-806. 1996
  • Endoscopic management of the obliterated anastomosis following radical prostatectomy..  156:70-72. 1996
  • Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting..  155:1667-1673. 1996
  • p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma..  155:1685-1692. 1996
  • Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy..  155:982-985. 1996
  • Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence..  155:512-514. 1996
  • Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy..  155:238-242. 1996
  • Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation..  154:1665-1669. 1995
  • Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients..  154:1676-1680. 1995
  • "Wildcatting" for breakthroughs in urothelial cancer detection and management--a frustrating business..  154:1348-1350. 1995
  • Partial nephrectomy: technique, complications and pathological findings..  154:1312-1318. 1995
  • Percutaneous endopyelotomy in infants and young children after failed open pyeloplasty..  154:1495-1497. 1995
  • Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer..  154:414-421. 1995
  • Are modern imaging techniques over diagnosing ureteropelvic junction obstruction?.  154:659-661. 1995
  • Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation..  154:456-459. 1995
  • Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation..  154:456-459. 1995
  • Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors..  154:617-621. 1995
  • Prostate cancer..  154:422-423. 1995
  • Radical retropubic prostatectomy: the influence of accessory pudendal arteries on the recovery of sexual function..  154:150-152. 1995
  • Neural control of urethral outlet activity in vivo: role of nitric oxide..  153:2004-2009. 1995
  • Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy..  153:1855-1859. 1995
  • Long-term outcome evaluation of patients undergoing the meatal advancement and glanuloplasty procedure..  153:1655-1656. 1995
  • Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer..  153:1674-1677. 1995
  • Extracorporeal shock wave lithotripsy for renal stones with renal cysts present..  153:599-601. 1995
  • Simplified urinary drainage following orthotopic or continent bladder replacement..  153:334-335. 1995
  • Editorial: Prostate Cancer.  154:422-423. 1995
  • Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy..  153:27-32. 1995
  • Lower pole calicostomy for the management of iatrogenic ureteropelvic junction obstruction..  153:142-145. 1995
  • Retroperitoneal pulmonary sequestration: a rare congenital anomaly in a 71-year-old man..  152:2341-2343. 1994
  • Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation..  152:1775-1780. 1994
  • Impact of radical prostatectomy in the management of clinically localized disease..  152:1826-1830. 1994
  • Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors..  152:1133-1138. 1994
  • Clinically detected carcinoma of the prostate treated by radical prostatectomy in a 29-year-old man..  152:966-967. 1994
  • Mortality of patients after radical prostatectomy: analysis of recent Medicare claims..  152:896-898. 1994
  • Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?.  152:393-396. 1994
  • Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density..  151:1565-1570. 1994
  • Corynebacterium induced urethral incrustation..  151:1636-1637. 1994
  • The effect of pelvic radiation therapy on serum levels of prostate specific antigen..  151:1579-1581. 1994
  • Synchronous management of anastomotic contracture and stress urinary incontinence following radical prostatectomy..  151:1202-1204. 1994
  • Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome..  151:640-645. 1994
  • Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction..  151:360-364. 1994
  • A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types..  151:49-53. 1994
  • Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder..  151:31-35. 1994
  • Laparoscopic dismembered pyeloplasty..  150:1795-1799. 1993
  • A comparison of the bioeffects of four different modes of stone therapy on renal function and morphology..  150:1267-1270. 1993
  • Possible mechanism for seeding of tumor during radical prostatectomy..  150:1169-1171. 1993
  • A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate..  150:845-848. 1993
  • Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors..  150:879-883. 1993
  • Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate..  150:546-551. 1993
  • Synchronous cystoscopy and cystometry in the management of neurogenic bladder dysfunction..  150:431-433. 1993
  • Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration..  150:142-146. 1993
  • Re: Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain..  150:201-202. 1993
  • The management of meatal obstruction due to Kaposi's sarcoma of the glans penis..  150:193-195. 1993
  • p53 gene alterations in human prostate carcinoma..  150:257-261. 1993
  • Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas..  149:1389-1394. 1993
  • Morphological and physiological changes in the urinary tract associated with ureteral dilation and ureteropyeloscopy: an experimental study..  149:1576-1585. 1993
  • Urological dysfunction in patients with diastematomyelia..  149:1503-1505. 1993
  • Congenital prostatic cyst causing ejaculatory duct obstruction: management by transrectal cyst aspiration..  149:1141-1143. 1993
  • Results of combined Nesbit penile plication with plaque incision and placement of Dacron patch in patients with severe Peyronie's disease..  149:1319-1320. 1993
  • Evidence for urothelial cell activation in interstitial cystitis..  149:470-475. 1993
  • Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy..  149:516-518. 1993
  • Infantile fibromatosis of the external genitalia: diagnosis and management strategy..  149:357-358. 1993
  • Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues..  149:170-173. 1993
  • Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial..  149:77-82. 1993
  • Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy..  149:109-111. 1993
  • Squamous cell carcinoma of the prostate: 2 cases of a rare malignancy and review of the literature..  149:137-139. 1993
  • Treatment philosophy and retreatment rates following piezoelectric lithotripsy..  149:12-14. 1993
  • Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization..  148:1822-1826. 1992
  • Hereditary renal cell carcinoma in the Eker rat: a rodent familial cancer syndrome..  148:1932-1936. 1992
  • Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades..  148:1401-1405. 1992
  • Successful outcome of artificial urinary sphincters in men with post-prostatectomy urinary incontinence despite adverse implantation features..  148:1166-1170. 1992
  • The value of urodynamic studies in infants less than 1 year old with congenital spinal dysraphism..  148:584-587. 1992
  • Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain..  148:409-411. 1992
  • A comparison of stone damage caused by different modes of shock wave generation..  148:200-205. 1992
  • Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum..  147:1650-1655. 1992
  • The development of a technique to estimate the number of motor units in the urethral sphincter..  147:1411-1415. 1992
  • The hemi-Kock ileocystoplasty: a versatile procedure in reconstructive urology..  147:1248-1251. 1992
  • Endoscopic release of retained Penrose drains: a simple solution for an old problem..  147:1067-1068. 1992
  • Alterations of the P53 gene are associated with the progression of a human prostate carcinoma..  147:789-793. 1992
  • Predicting and monitoring results of therapy..  147:967. 1992
  • Radical prostatectomy: the pros and cons of the perineal versus retropubic approach..  147:888-890. 1992
  • Retroaortic left renal vein in testicular cancer patient: potential staging and treatment pitfall..  147:454-456. 1992
  • Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections..  147:386-388. 1992
  • Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction..  147:192-196. 1992
  • Immunoreactive prostatic specific antigen in male periurethral glands..  147:246-248. 1992
  • Management of the bladder outlet in patients requiring enterocystoplasty..  147:38-41. 1992
  • Retroperitoneal fibrosis following radiotherapy for stage I testicular seminoma..  147:124-126. 1992
  • Rupture of the deep dorsal vein of the penis during sexual intercourse..  147:150-152. 1992
  • The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer..  146:1418-1424. 1991
  • Celiac axis and superior mesenteric artery injury associated with left radical nephrectomy for locally advanced renal cell carcinoma..  146:1104-1107. 1991
  • Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1)..  146:915-919. 1991
  • Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study..  145:1178-1183. 1991
  • A comparison of renal damage induced by varying modes of shock wave generation..  145:864-867. 1991
  • Repair of pelvic fracture posterior urethral defects using an elaborated perineal approach: experience with 74 cases..  145:744-748. 1991
  • Temporal effects of shock wave lithotripsy..  145:881-883. 1991
  • An objective score to predict upper tract deterioration in myelodysplasia..  145:535-537. 1991
  • Surgical management and prognosis of renal cell carcinoma invading the vena cava..  145:20-23. 1991
  • Salvage posterior urethroplasty after failed initial repair of pelvic fracture membranous urethral defects..  144:1370-1372. 1990
  • Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results..  144:1180-1184. 1990
  • Augmentation cystoplasty complicated by postoperative ventriculoperitoneal shunt infection..  144:955-956. 1990
  • Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers..  144:1004-1009. 1990
  • Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells..  144:614-617. 1990
  • Voiding dysfunction following cystourethropexy: its evaluation and management..  144:670-673. 1990
  • The outcome of transvaginal cystourethropexy in patients with anatomical stress urinary incontinence and outlet weakness..  144:106-108. 1990
  • Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule..  143:1178-1182. 1990
  • Brucella orchitis: a rare cause of testicular enlargement..  143:821-822. 1990
  • Delay in diagnosis and survival in testicular cancer: impact of effective therapy and changes during 18 years..  143:520-523. 1990
  • Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?.  143:458-463. 1990
  • Laxative abuse as a cause for ammonium urate renal calculi..  143:244-247. 1990
  • Augmentation cystoplasty complicated by postoperative ventriculoperitoneal shunt infection: Reply by authors.  144:956. 1990
  • Epidermal growth factor receptor gene analysis in renal cell carcinoma..  143:191-193. 1990
  • Impotence following delayed repair of prostatomembranous urethral disruption: Editorial comment.  144:678. 1990
  • The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer: Editorial comment (I).  144:1170. 1990
  • Complications of therapy for testicular cancer..  142:1491-1496. 1989
  • Lessons learned in patients with large steinstrasse..  142:1425-1427. 1989
  • Bladder perforation secondary to clean intermittent catheterization..  142:1316-1317. 1989
  • Clinically occult Leydig cell tumor presenting with gynecomastia..  142:1325-1327. 1989
  • Prostate cancer with solitary parotid metastasis correctly diagnosed with immunohistochemical stains..  142:1328-1329. 1989
  • The detection of renal carcinoma extension into the renal vein and inferior vena cava: a prospective comparison of venacavography and magnetic resonance imaging..  142:943-947. 1989
  • Negative pressure devices in the explanted penile prosthesis population..  142:729-731. 1989
  • Rationale for immunotoxin therapy of metastatic prostate carcinoma formatted as a multi-stage delivery system..  142:425-432. 1989
  • Risk factors for perineal seeding of prostate cancer after needle biopsy..  142:86-88. 1989
  • Ureteral stenting during extracorporeal shock wave lithotripsy: help or hindrance?.  142:32-36. 1989
  • Acute urinary retention associated with prostatic carcinoma..  141:1375-1377. 1989
  • A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections..  141:575-578. 1989
  • The management of chronic interstitial cystitis by substitution cystoplasty..  141:287-291. 1989
  • Candida albicans corpora abscess following penile prosthesis placement..  140:1541-1542. 1988
  • Localized amyloidosis of the urethra: diagnostic implications and management..  140:1536-1538. 1988
  • The natural course of prostatic carcinoma in relation to initial cytological grade..  140:1452-1454. 1988
  • Renovascular hypertension..  140:911-924. 1988
  • Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence..  140:769-774. 1988
  • Radical prostatectomy in stage A prostatic adenocarcinoma..  140:535-539. 1988
  • Adult segmental cystic disease of the kidney: a renal-sparing management approach..  140:357-359. 1988
  • A review of surgical treatment of undescended testes with emphasis on anatomical position..  140:125-128. 1988
  • Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma..  140:96-100. 1988
  • The clinical significance of unconventional orchiectomy approaches in testicular cancer: a report from the Testicular Cancer Intergroup Study..  139:1225-1228. 1988
  • Treatment of ureteral calculi by extracorporeal shock wave lithotripsy at a multi-use center..  139:1192-1194. 1988
  • Urinary glycosaminoglycans in normal subjects and patients with stones..  139:995-997. 1988
  • Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate..  139:240-242. 1988
  • Percutaneous lithotripsy in morbid obesity..  139:243-245. 1988
  • Late hematogenous infection of penile prostheses..  139:50-52. 1988
  • Massive retroperitoneal hemorrhage owing to a ruptured adrenal cyst..  139:98-100. 1988
  • Extracorporeal shock wave lithotripsy: the use of chemical treatments for improved stone comminution..  138:1295-1300. 1987
  • CYSTOMETRIC PROPERTIES OF ILEUM AND RIGHT COLON AFTER BLADDER AUGMENTATION, SUBSTITUTION OR REPLACEMENT.  138:1007-1008. 1987
  • Cystometric properties of ileum and right colon after bladder augmentation, substitution or replacement..  138:1007-1008. 1987
  • Experiences with bladder reconstruction in children..  138:1002-1006. 1987
  • Does transurethral resection of the prostate promote metastatic disease?.  138:90-91. 1987
  • Intravenous digital subtraction angiography in the evaluation of potential renal donors..  138:28-32. 1987
  • Development and characterization of a monoclonal antibody to human embryonal carcinoma..  137:1295-1299. 1987
  • Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria..  137:1104-1109. 1987
  • Cephalad renal movement during percutaneous nephrostolithotomy..  137:623-625. 1987
  • Intraoperative management of penile erection with intracorporeal phenylephrine during endoscopic surgery..  137:738-739. 1987
  • Fournier's gangrene: a complication of penile prosthetic implantation in a renal transplant patient..  137:299-300. 1987
  • Radical prostatectomy: anatomical predictors of success or failure..  136:1041-1043. 1986
  • Factors affecting the success rate of percutaneous nephrolithotripsy and the incidence of retained fragments..  136:358-360. 1986
  • Outpatient percutaneous nephrostolithotomy..  136:355-357. 1986
  • Comparison of the costs and morbidity of percutaneous and open flank procedures..  135:1150-1152. 1986
  • Experience with the AMS 600 malleable penile prosthesis..  135:929-931. 1986
  • Use of the rectus abdominis muscle flap in urological reconstructive procedures..  135:963-965. 1986
  • INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY IN THE EVALUATION OF POTENTIAL RENAL DONORS.  135:A318-A318. 1986
  • VESICAL PYELOSTOMY IN THE MANAGEMENT OF RENAL-TRANSPLANT COMPLICATIONS.  135:A317-A317. 1986
  • Continent catheterizable urinary diversion using the ileocecal segment with stapled intussusception of the ileocecal valve..  135:465-469. 1986
  • Augmentation and substitution enterocystoplasty..  135:215-224. 1986
  • Perineal transpubic repair: a technique for treating post-traumatic prostatomembranous urethral strictures..  135:278-279. 1986
  • Calcium stone disease: an overview..  135:1-9. 1986
  • Chylothorax: a rare complication of metastatic prostatic carcinoma..  134:1215-1217. 1985
  • The management of the Kock continent ileal reservoir urinary diversion with single pigtail self-retaining ileal conduit stents..  134:1104-1106. 1985
  • Ejaculatory duct obstruction: the case for aggressive diagnosis and treatment..  134:964-966. 1985
  • Urethroplasty management in 100 cases of urethral stricture: a rationale for procedure selection..  134:892-898. 1985
  • Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity..  134:658-661. 1985
  • Overflow urinary incontinence due to carbamazepine..  134:758-759. 1985
  • Lumbosacral plexus stretch injury following the use of the modified lithotomy position..  134:567-568. 1985
  • The management of strictures of the membranous urethra..  134:469-473. 1985
  • Continent urinary diversion..  134:227-236. 1985
  • Long-term treatment of calcium nephrolithiasis with potassium citrate..  134:11-19. 1985
  • Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis..  134:20-23. 1985
  • The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal..  134:6-10. 1985
  • Lethal complications of standard self-retaining ureteral stents in patients with ileal conduit urinary diversion..  133:851-853. 1985
  • Percutaneous ureterolithotomy..  133:671-673. 1985
  • Re: Morbidity of radical perineal prostatectomy following transurethral resection of the prostate..  133:691. 1985
  • The vascularized skin island urethroplasty: its role and results in urethral stricture management..  133:31-33. 1985
  • Acute renal failure due to perirenal hematoma complicating open renal biopsy..  132:969-971. 1984
  • Urethrovaginal fistula: a review of the surgical management..  132:460-462. 1984
  • Urodynamic abnormalities in neurologically normal children with micturition dysfunction..  132:74-77. 1984
  • Spontaneously acquired anti-factor VIII antibodies: report of a patient with adenocarcinoma of the prostate..  131:1182-1184. 1984
  • Suboptimal results in full thickness skin graft urethroplasty using an extrapenile skin donor site..  131:1082-1083. 1984
  • Dietary management of idiopathic calcium urolithiasis..  131:850-852. 1984
  • Familial visceral myopathy..  131:978-980. 1984
  • Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate..  131:901-902. 1984
  • Re: Review of delayed orchiectomy in patients with disseminated testis tumors..  131:560. 1984
  • Surgical correction of Peyronie's disease: the Nesbit procedure..  131:282-285. 1984
  • Troubleshooting the malfunctioning Scott artificial urinary sphincter..  131:269-272. 1984
  • Prostatomembranous urethral injuries: a review of the literature and a rational approach to their management..  130:898-902. 1983
  • Acute urinary retention in female patients: diagnosis and treatment..  130:112-113. 1983
  • Urodynamic characterization of incontinence in the elderly by bladder volume..  129:772-774. 1983
  • The predictive value of 2,-4, dinitrochlorobenzene skin testing in patients with bilharzial bladder cancer..  129:499-501. 1983
  • Why do secondary cadaver renal transplants succeed? Results of the South-Eastern Organ Procurement Foundation prospective study, 1977-1982..  129:484-488. 1983
  • Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice..  128:1064-1067. 1982
  • Radical surgery versus radiotherapy for adenocarcinoma of the prostate..  128:502-504. 1982
  • Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma..  127:935-937. 1982
  • Murine congenital polycystic kidney disease: a model for studying development of cystic disease..  127:556-560. 1982
  • Simultaneous assessment of human sperm motility and morphology by videomicrography..  126:357-360. 1981
  • Neurogenic bladder dysfunction in the Shy-Drager syndrome..  126:119-121. 1981
  • Prognosis of patients with stage D1 prostatic adenocarcinoma..  125:817-819. 1981
  • Anterior urethral polyps: an unusual cause of hematuria in a child..  125:744-745. 1981
  • In vitro chemotherapeutic testing of urologic tumors..  125:490-492. 1981
  • The primary megacystis syndrome..  125:232-234. 1981
  • Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit..  124:849-850. 1980
  • Experience with Gleason's histopathologic grading in prostatic cancer..  124:223-225. 1980
  • Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study..  123:697-699. 1980
  • The evaluation of bladder neck dysfunction..  123:196-198. 1980
  • Traumatic rupture of the female urethra..  122:560-561. 1979
  • Renal metastasis of adenocarcinoma of the lung: massive hematuria managed by therapeutic embolization..  122:398-400. 1979
  • Cortisone acetate versus clomiphene citrate in per-germinal idiopathic oligospermia..  121:432-434. 1979
  • Primary non-urachal adenocarcinoma of the bladder..  121:278-281. 1979
  • The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma..  121:300-302. 1979
  • Ultrasound-guided percutaneous nephrostomy in the pediatric patient..  121:327-329. 1979
  • Trimethoprium-sulfamethoxazole and minocycline- hydrochloride in the treatment of culture-proved bacterial prostatitis..  120:184-185. 1978
  • Extraperitoneal gas following nephrectomy: patterns and duration..  120:24-27. 1978
  • Staging profile of hypofertile male subjects..  120:71-72. 1978
  • The effects of castration on adrenal testosterone secretion in men with prostatic carcinoma..  118:1019-1021. 1977
  • Obstruction of the male reproductive tract..  118:266-268. 1977
  • Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma..  117:618-621. 1977
  • Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report..  117:467-471. 1977
  • Techniques and results of urodynamic evaluation of children..  117:346-349. 1977
  • The clinical spectrum of prostate cancer..  117:323-327. 1977
  • Surgical validation of angiographic studies of renal lesions..  116:550-552. 1976
  • Antigenic activity of human urothelial tissue..  115:288-292. 1976
  • Clomiphene citrate in the management of male infertility..  115:73-76. 1976
  • Medrogestone: a prospective study in the pharmaceutical management of benign prostatic hyperplasia..  113:811-815. 1975
  • Detection of oncornavirus antigenic activity in human urothelial tissues..  113:658-662. 1975
  • Post-obstructive diuresis: a varied syndrome..  113:190-194. 1975
  • Lesions of bone and bladder cancer..  113:45-46. 1975
  • Carcinoma of the male urethra..  112:610-613. 1974
  • Response of human urothelium to chemical carcinogens in vitro..  111:154-159. 1974
  • Retrograde urethrogram: diagnostic aid and hazard..  110:462-466. 1973
  • The histopathology of vesical diverticula..  110:62-64. 1973
  • Methoxyflurane-induced renal dysfunction..  109:945-946. 1973
  • Transient significant bacteriuria in women..  109:464-466. 1973
  • Retrograde urethrogram: Diagnostic aid and hazard.  110:464-466. 1973
  • Pediatric urolithiasis..  108:811-814. 1972
  • Urologic complications in renal transplantation..  107:187-192. 1972
  • Electron microscopic virus-like material in systemic lupus erythematosus: with preliminary immunologic observations on presence of measles antigen..  105:615-619. 1971
  • Sequential changes in bulk renal protein and polyribosomes in the acutely obstructed mouse kidney..  103:257-261. 1970
  • Treatment of late complications of ileal conduit..  102:320-324. 1969
  • A simple method of transurethral photography..  101:752-753. 1969
  • Morphological and biochemical studies of virus (SV40) transformed prostatic tissue..  101:735-740. 1969
  • A granuloma of the testis of unknown etiology..  67:342-349. 1952
  • Diagnosis of bladder tumor..  64:464-468. 1950
  • Re: Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.  186:1880-1881. 2011
  • Editorial Comment.  181:591. 2009
  • Urothelial Sloughing With Obstruction After Laparoscopic Cryoablation of Small Renal Carcinoma in Solitary Kidney Editoral Comment.  181:1602-1602. 2009
  • Editorial Comment.  180:1604. 2008
  • Editorial Comment.  180:1599. 2008
  • Editorial Comment.  179:2206. 2008
  • Editorial Comment.  179:2356. 2008
  • Editorial Comment.  179:2206-2206. 2008
  • Editorial Comment.  179:2356-2356. 2008
  • Re: A Critical Assessment of the Quality of Reporting of Randomized, Controlled Trials in the Urology Literature.  179:2488-2489. 2008
  • Re: A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature - Reply.  179:2489-2489. 2008
  • Editorial Comment.  180:1592-1593. 2008
  • Editorial Comment.  179:161-162. 2008
  • Editorial Comment.  180:902-903. 2008
  • A Users' Guide to the Urological Literature: Introducing a Series of Evidence Based Medicine Review Articles.  178:1149. 2007
  • Editorial Comment.  176:1830. 2006
  • Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006..  176:1252-1253. 2006
  • Editorial comment.  175:2169. 2006
  • Editorial comment.  175:2268. 2006
  • Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial..  175:1960. 2006
  • Editorial Comment.  176:1337-1338. 2006
  • Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: Results from CaPSURE - Commentary.  175:129. 2006
  • Jejunoileal bypass reversal: Effect on renal function, metabolic parameters and stone formation. Editorial comment.  174:1846. 2005
  • Urolithiasis, endourology and laparoscopy.  173:1199-1201. 2005
  • Stone formation is proportional to papillary surface coverage by Randall's plaque - Editorial comment.  173:119-119. 2005
  • Re: the economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data..  172:2484. 2004
  • Re: Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy..  170:2392. 2003
  • Oxaluria--the neglected stepchild of nephrolithiasis?.  170:402-403. 2003
  • Editorial comment.  167:854-854. 2002
  • Prostate biopsy quantitative histology as a staging and prognostic factor..  167:526-527. 2002
  • Re: The development of erectile dysfunction in men treated for prostate cancer..  166:1010. 2001
  • A computer generated interactive transurethral prostatic resection simulator - Comment.  162:1635-1635. 1999
  • Time to stone passage for observed ureteral calculi: A guide for patient education - Editorial comment.  162:690-691. 1999
  • Unenhanced computerized axial tomography to detect retained calculi after percutaneous ultrasonic lithotripsy - Comment.  162:314-314. 1999
  • Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis - Comment.  161:1452-1452. 1999
  • Re: Outcome based comparison of surgical approaches for pediatric pyeloplasty: dorsal lumbar versus flank incision..  161:923. 1999
  • Re: Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain..  161:926. 1999
  • URETEROSCOPIC TREATMENT OF URETEROPELVIC JUNCTION OBSTRUCTION.  1646-1647. 1998
  • Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.  158:2073-2073. 1997
  • Prostate cancer 1997--practicing what we preach..  158:1859-1860. 1997
  • Stent-free Thiersch-Duplay hypospadias repair with the Snodgrass modification..  158:1178-1180. 1997
  • The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion - Comment.  158:37-37. 1997
  • Radical prostatectomy and cryotherapy--some answers, more questions..  157:256-257. 1997
  • Nephrolithiasis--solutions for emerging problems..  156:910-911. 1996
  • Clinical implications of clinically insignificant stone fragments after extracorporeal shock wave lithotripsy - Comment.  155:1190-1190. 1996
  • Shock wave lithotripsy: what progress have we made? Are refinements needed?.  153:602-603. 1995
  • EFFECT OF MEDICAL-MANAGEMENT AND RESIDUAL FRAGMENTS ON RECURRENT STONE FORMATION FOLLOWING SHOCK-WAVE LITHOTRIPSY - REPLY.  153:33-33. 1995
  • Gangrene of the penis after implantation of penile prosthesis: case reports, treatment recommendations and review of the literature..  150:190-191. 1993
  • High pressure versus low pressure electromagnetic extracorporeal lithotripsy..  149:988-991. 1993
  • Re: Detection of human papillomavirus in squamous neoplasm of the penis..  149:869. 1993
  • Long-term results with vacuum constriction device..  149:290-294. 1993
  • Efficacy of second generation lithotriptors: a multicenter comparative study of 2,206 extracorporeal shock wave lithotripsy treatments with the Siemens Lithostar, Dornier HM4, Wolf Piezolith 2300, Direx Tripter X-1 and Breakstone lithotriptors..  148:1052-1056. 1992
  • Renal function immediately after piezoelectric extracorporeal lithotripsy: Editorial comment (I).  144:12. 1990
  • Nephrolithiasis from calcium supplementation..  137:1212-1213. 1987
  • BIPARAMETRIC QUANTITATIVE MRI FOR PROSTATE CANCER DETECTION 2022
  • COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN SINGLE-PORT AND MULTIPORT RETROPERITONEAL ROBOT-ASSISTED PARTIAL NEPHRECTOMIES 2022
  • LONGITUDINAL OUTCOMES FOLLOWING IMPLEMENTATION OF BASELINE PSA RISK STRATIFICATION OF MEN IN THEIR FORTIES 2022
  • PREDICTING PROFICIENCY DURING ROBOTIC PROSTATECTOMY OF UROLOGY TRAINEES USING A NOVEL, SYSTEMIC SURGICAL TRAINING PROGRAM 2022
  • RELATIONSHIPS BETWEEN LONGITUDINAL URINARY SYMPTOMS AND PHYSICAL AND PSYCHOSOCIAL FACTORS IN WOMEN IN THE SYMPTOMS OF LOWER URINARY TRACT DYSFUNCTION RESEARCH NETWORK 2022
  • RURAL HOSPITAL LOCATION IS ASSOCIATED WITH HIGHER REPORTED PRICES FOR URETEROSCOPY WITH LASER LITHOTRIPSY AMONG COMMERCIALLY INSURED PATIENTS 2022
  • A SYSTEMATIC REVIEW OF CLINICAL SIGNS AND SYMPTOMS, PREDICTION RULES AND IMAGING MODALITIES IN PATIENTS WITH SUSPECTED RENAL COLIC 2021
  • OUTCOMES OF AN ALGORITHMIC, MULTIDISCIPLINARY APPROACH TO RECTOURETHRAL FISTULA REPAIR; A PRE- AND POST-INTERVENTION QUASI-EXPERIMENTAL STUDY 2021
  • PREDICTING POSTOPERATIVE COMPLICATIONS IN PEDIATRIC SURGERY: A NOVEL COMORBIDITY INDEX FOR PATIENT RISK STRATIFICATION 2021
  • PROGRESSION ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER IN BLACK MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS 2021
  • DOES ABDOMINAL AND PELVIC ADIPOSE TISSUE DISTRIBUTION IMPACT PROSTATE CANCER-SPECIFIC OUTCOMES AFTER RADIATION THERAPY? 2020
  • INTRAOPERATIVE PREDICTORS OF SACRAL NEUROMODULATION IMPLANTATION & TREATMENT RESPONSE - RESULTS FROM THE ROSETTA TRIAL 2020
  • KIDNEY STONE RISK AND ASSOCIATION WITH URINE OXALATE (UOX) LEVELS IN ENTERIC HYPEROXALURIA (EH) 2020
  • SAFETY PROFILE OF COUNTER INCISION FOR RESERVOIR PLACEMENT DURING INFLATABLE PENILE PROSTHESIS SURGERY 2020
  • ACCELERATING THE LEARNING CURVE: A NOVEL EXPERT COACHING MODEL IN UROLOGY 2020
  • ANNEXIN A1 INHIBITS NLRP3 AND PREVENTS INFLAMMATION DURING BLADDER OUTLET OBSTRUCTION 2020
  • ETHNIC VARIATION IN PROSTATE CANCER DETECTION: A HYPOTHESIS GENERATING STUDY FOR USE OF THE STOCKHOLM3 TEST IN AN AMERICAN COHORT 2020
  • INCREASING UTILIZATION OF MAGNETIC RESONANCE IMAGING (MRI) PRIOR TO PROSTATE BIOPSY IN BLACK AND NON-BLACK MEN: AN ANALYSIS OF THE SEER-MEDICARE COHORT 2020
  • MICROWAVE ABLATION OF RENAL CELL CARCINOMA: ONCOLOGIC AND FUNCTIONAL OUTCOMES AT A SINGLE CENTER 2020
  • PERSONAL CHARACTERISTICS ASSOCIATED WITH 30-DAY RECALL OF SELF-REPORTED LOWER URINARY TRACT SYMPTOMS 2020
  • SPINK1 IS ASSOCIATED WITH CASTRATION RESISTANCE IN PROSTATE CANCER 2020
  • THE ASSOCIATION OF CANCER SPECIFIC ANXIETY WITH DISEASE AGGRESSIVENESS IN MEN ON ACTIVE SURVEILLANCE OF PROSTATE CANCER 2020
  • THE ENDOGENOUS ANTI-INFLAMMATORY ANNEXIN A1 AUGMENTS RECOVERY FOLLOWING BLADDER OUTLET DE-OBSTRUCTION 2020
  • Financial Margins for Prostate Cancer Surgery: Quantifying the Impact of Modifiable Cost Inputs in an Episode Based Reimbursement Model. 2019
  • ARTIFICIAL URINARY SPHINCTER IMPLANTATION IS A SAFE PROCEDURE WITH LOW COMPLICATION RATES EVEN IN THE ELDERLY AND COMORBID POPULATION 2019
  • CYCLOPHOSPHAMIDE-INDUCED CYSTITIS TRIGGERS NLRP3-DEPENDENT NEUROINFLAMMATION IN THE HIPPOCAMPUS AND DEPRESSION IN RATS 2019
  • INCREASING ADIPOSITY IN BLADDER CANCER SURVIVORS: DOES DIET MATTER? 2019
  • LONGITUDINAL CHANGES IN SYMPTOM-BASED FEMALE AND MALE LUTS CLUSTER CHARACTERISTICS AND FACTORS ASSOCIATED WITH CHANGE 2019
  • OUTCOMES OF RECTO-URETHRAL FISTULA REPAIR USING A YORK-MASON PROCEDURE - RETURN TO CONTINUITY OF URINARY AND BOWEL FUNCTION 2019
  • SACRAL NEUROMODULATION: DETERMINING PREDICTORS OF SUCCESS 2019
  • SHORT-TERM SUCCESS DOES NOT GUARANTEE LONG-TERM OUTCOMES IN THE RADIATED RECTO-URETHRAL FISTULA REPAIR PATIENT 2019
  • A NEW BRIEF LOWER URINARY TRACT SYMPTOMS CLINICAL ASSESSMENT TOOL FOR WOMEN AND MEN: THE LURN SYMPTOM INDEX 2019
  • ACCURACY OF 7-AND 30-DAY RECALL FOR SELF-REPORTED LOWER URINARY TRACT SYMPTOMS 2019
  • CHARACTERISTICS OF HIGH LOWER URINARY TRACT SYMPTOM (LUTS) BOTHER IN INDIVIDUALS SEEKING CARE FOR LUTS 2019
  • CORRELATION OF SYMPTOM SEVERITY AND BOTHER IN INDIVIDUALS SEEKING CARE FOR LOWER URINARY TRACT SYMPTOMS 2019
  • DIAGNOSTIC PROPERTIES OF PROSTATE-SPECIFIC ANTIGEN TO PREDICT PROSTATE CANCER AND CLINICALLY SIGNIFICANT PROSTATE CANCER AMONG MEN WITH ANDROGEN DEFICIENCY 2019
  • IMPROVED ACCURACY OF MRI/US FUSION PROSTATE BIOPSY USING A STRETCHED EXPONENTIAL DIFFUSION PARAMETER 2019
  • SIGNIFICANCE OF CANONICAL WNT10B IN PROSTATE GLAND DEVELOPMENT AND CARCINOGENESIS 2019
  • SYSTEMIC METABOLIC RESPONSES OF PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) WITH AND WITHOUT LOW CARB DIET 2019
  • THE EFFECT OF CONDUCTIVE HYPERTHERMIA ON MITOMYCIN C ABSORPTION DURING INTRAVESICAL CHEMOTHERAPY 2019
  • THE POTENTIAL FOR CIRCULATING EXTRACELLULAR VESICLE MICRORNAS TO PREDICT PROSTATE CANCER AGGRESSIVENESS 2019
  • TOXICITY AND BIODISTRIBUTION OF GOLD NANOPARTICLE-BASED PHOTO-IMMUNO-NANOTHERAPY FOR BLADDER CANCER 2019
  • COMPONENTS OF URINARY STONES ACTIVATE THE NLRP3 INFLAMMASOME IN BLADDER UROTHELIUM 2018
  • EVALUATION OF THE UROVYSION (TM) TEST FOR PREDICTING RECURRENCE AND PROGRESSION IN PATIENTS RECEIVING BCG FOR HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER 2018
  • NLRP3 INFLAMMASOME MEDIATED INFLAMMATION AND DENERVATION ARE CRITICAL PROCESSES IN THE DEVELOPMENT OF DIABETIC BLADDER DYSFUNCTION 2018
  • OPEN VERSUS ROBOTIC URETERONEOCYSTOSTOMY FOR PEDIATRIC VESICOURETERAL REFLUX: A SYSTEMATIC REVIEW 2018
  • PHARMACOLOGICAL INHIBITION OF THE NLRP3 INFLAMMASOME PREVENTS BLADDER DECOMPENSATION IN A RAT MODEL OF CHRONIC BLADDER OUTLET OBSTRUCTION 2018
  • REAL-TIME IMAGING DEMONSTRATING T-CELL MEDIATED DESTRUCTION OF PROSTATIC ACID PHOSPHATASE (PAP)-EXPRESSING CELLS IN PATIENTS (PTS) TREATED WITH SIPULEUCEL-T (SIP-T) 2018
  • REGULATION OF CONJUGATIVE TRANSFER OF beta-LACTAM RESISTANCE FROM UROPATHOGENIC STRAINS OF ESCHERICHIA COLI 2018
  • SECONDARY OUTCOMES OF A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1) 2018
  • SIPULEUCEL-T IMMUNOTHERAPY FOR CASTRATE-RESISTANT PROSTATE CANCER MODULATES SOLUBLE B7-H3: A NOVEL MECHANISM OF ACTION 2018
  • A FIRST LOOK AT INPATIENT TREATMENT FOR PROSTATE CANCER IN MEN WITH SPINA BIFIDA 2018
  • ASSOCIATION BETWEEN ENVIRONMENTAL QUALITY AND PROSTATE CANCER STAGE AT DIAGNOSIS 2018
  • BLACK RACE PREDICTS SIGNIFICANT PROSTATE CANCER INDEPENDENT OF CLINICAL SETTING, AND CLINICAL AND SOCIOECONOMIC RISK FACTORS: EVIDENCE FOR A BIOLOGICAL BASIS OF DISPARITIES 2018
  • DYNAMIC MAGNETIC RESONANCE ANGIOGRAPHY IN MEN WITH IDIOPATHIC ERECTILE DYSFUNCTION 2018
  • NATIONAL IMAGING AND ANTIBIOTIC PRACTICE PATTERNS IN CHILDREN PRESENTING WITH URINARY TRACT INFECTION: LITTLE IMPACT OF AAP GUIDELINES? 2018
  • MP01-07 THE ADDED UTILITY OF DIGITAL TOMOSYNTHESIS TO STANDARD ABDOMINAL RADIOGRAPHY FOR IDENTIFICATION OF URINARY CALCULI 2017
  • MP01-19 RECENT EPIDEMIOLOGICAL AND METABOLIC TRENDS IN STONE DISEASE: RISING HYPOCITRATURIA AND HYPEROXALURIA 2017
  • MP100-13 IRREVERSIBLE ELECTROPORATION FOR RENAL MASSES NOT AMENABLE TO THERMAL ABLATION IN NON-SURGICAL CANDIDATES: MID-TERM CLINICAL FOLLOW-UP 2017
  • MP11-15 PREDICTORS OF FLUOROQUINOLONE RESISTANCE IN THE RECTAL VAULT OF MEN UNDERGOING PROSTATE BIOPSY 2017
  • MP13-13 DOES TREATING NOCTURIA LEAD TO BETTER SLEEP? RESULTS FROM REDUCE 2017
  • MP14-13 CHANGES IN HEALTH-RELATED QUALITY OF LIFE AMONG OLDER ADULTS WITH PROSTATE CANCER: A CASE-CONTROL STUDY 2017
  • MP23-20 NLRP3/IL-1β MEDIATES DENERVATION DURING BLADDER OUTLET OBSTRUCTION IN RATS 2017
  • MP25-19 SURVEY ON THE CONTEMPORARY MANAGEMENT OF INTRAOPERATIVE URETHRAL INJURIES DURING PENILE PROSTHESIS IMPLANTATION 2017
  • MP38-12 PROPENSITY SCORE ANALYSIS OF PATHOLOGICAL OUTCOME AT RADICAL PROSTATECTOMY FOR MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND FUSION PROSTATE BIOPSY VERSUS UNTARGETED EXTENDED TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY 2017
  • MP65-08 HEAT-TARGETED DRUG DELIVERY USING THE COMBAT BRS DEVICE FOR TREATING BLADDER CANCER 2017
  • MP85-02 ABERRANT BLADDER REFLEXES CAN DRIVE HIND LIMB LOCOMOTOR ACTIVITY FOLLOWING COMPLETE SUPRASACRAL SPINAL CORD INJURY 2017
  • MP95-05 INCREASING UTILIZATION OF CARE FOR URINARY STONE DISEASE IN OLDER ADULTS 2017
  • MP98-09 SYNERGISTIC IMMUNO-PHOTOTHERMAL NANOTHERAPY (SYMPHONY): A NOVEL TREATMENT FOR LOCALIZED AND METASTATIC BLADDER CANCER 2017
  • MP99-03 RIOK2 IS A MEDIATOR OF OBESITY ENHANCED PROSTATE CANCER GROWTH 2017
  • PD03-10 VALIDATION OF THE 2015 PROSTATE CANCER PROGNOSTIC GRADE GROUPS FOR PREDICTING LONG-TERM ONCOLOGIC OUTCOMES IN A SHARED EQUAL ACCESS HEALTH SYSTEM. 2017
  • PD10-11 ANALYSIS OF THE PREDICTIVE UTILITY OF PROGNOSTIC GRADE GROUPS (PGG) FOR PREDICTING PERIOPERATIVE ONCOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE 2017
  • PD12-06 INFLAMMASOME ACTIVATION EARLY IN THE DEVELOPMENT OF DIABETIC BLADDER DYSFUNCTION 2017
  • PD54-05 DEMOGRAPHIC AND CLINICAL VARIABLES ASSOCIATED WITH TREATMENT RESPONSE IN WOMEN UNDERGOING ONABOTULINUMTOXINA AND SACRAL NEUROMODULATION 2017
  • MP01-06 DRAMATIC RACIAL DISPARITIES IN DIETARY MICRONUTRIENT INTAKE AMONG BLADDER CANCER SURVIVORS 2016
  • MP01-08 NO DIFFERENCE IN PHYSICAL ACTIVITY IN BLADDER CANCER SURVIVORS TREATED WITH TRANSURETHRAL RESECTION OR RADICAL CYSTECTOMY. 2016
  • MP01-09 CAN A GENE METHYLATION ASSAY IMPROVE THE PERFORMANCE OF CYTOLOGY? 2016
  • MP04-06 A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1) 2016
  • MP18-11 MR-GUIDED FOCAL LASER ABLATION OF INTERMEDIATE RISK PROSTATE CANCER: PHASE I TRIAL 2016
  • MP21-16 3T MULTI-PARAMETRIC MRI PERFORMANCE IN PROSTATE CANCER DETECTION: PERIPHERAL ZONE TUMORS VS. TRANSITIONAL ZONE 2016
  • MP24-17 PERVASIVE BIOFILM COVERAGE: AN ANALYSIS OF BIOFILM FORMATION IN INDWELLING URINARY CATHETERS 2016
  • MP51-14 PERCUTANEOUS NEPHROLITHOTOMY AFTER RECENT UROLITHIASIS RELATED SEPSIS: WHAT SHOULD PATIENTS EXPECT? ANSWERS FROM A MATCHED PAIR ANALYSIS 2016
  • PD09-08 SHOULD A MAN WITH A HISTORY OF BREAST CANCER BE SCREENED FOR PROSTATE CANCER? 2016
  • PD10-07 FASTER CARE FOR LESS? COST MODEL OF HEMATURIA CARE REDESIGN 2016
  • PD47-06 DISPROPORTIONATE USE OF INPATIENT CARE BY OLDER ADULTS WITH URINARY STONE DISEASE 2016
  • MP14-13 WEIGHING IN ON ACTIVE SURVEILLANCE: IMPACT OF OBESITY ON PATIENT COUNSELING 2015
  • MP28-05 URETEROSCOPIC REMOVAL OF CALCULUS IN POORLY FUNCTIONING (<10%) KIDNEYS DUE TO URETERIC STONE: A PROSPECTIVE OUTCOME ANALYSIS 2015
  • MP44-01 A PROGNOSTIC MODEL FOR OVERALL SURVIVAL IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CARCINOMA: RESULTS FROM CALGB 90206 (ALLIANCE) 2015
  • MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT 2015
  • MP59-01 IMPACT OF BLOOD TRANSFUSIONS ON ONCOLOGICAL OUTCOMES OF SURGICALLY TREATED LOCALIZED RENAL CELL CARCINOMA 2015
  • MP88-06 THE MECHANISM OF ACTION OF THE MALE TRANSOBTURATOR SLING IS VIA INCREASED FUNCTIONAL LENGTH OF THE MEMBRANOUS URETHRA: A PROSPECTIVE, CONTROLLED STUDY USING DYNAMIC MRI 2015
  • PD17-06 RANDOMIZED PHASE II TRIAL OF INTRAVESICAL ADENOVIRAL MEDIATED INTERFERON-α GENE THERAPY WITH THE EXCIPIENT SYN3 (RAD-IFNα/SYN3) IN PATIENTS WITH BCG REFRACTORY OR RELAPSING HIGH GRADE (HG) NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) 2015
  • MP39-06 WHOLE EXOME SEQUENCING OF THE CANCER GENOME IN PATIENTS WITH VERY HIGH RISK MUSCLE INVASIVE BLADDER CANCER 2014
  • MP42-16 COMPARISON OF THE PREDICTIVE ACCURACY OF THE PARTIN TABLES VS MULTI-PARAMETRIC MRI IN FORECASTING ORGAN-CONFINED PROSTATE CANCER 2014
  • PD27-09 MANAGEMENT OF RECURRENT PROSTATE CANCER AFTER RADIOTHERAPY: LONG-TERM RESULTS FROM CALGB 9687, A CONTEMPORARY PROSPECTIVE MULTI-INSTITUTIONAL SALVAGE PROSTATECTOMY SERIES 2014
  • PD3-06 OPTIMIZING THE MANAGEMENT OF SURGICAL AND ABLATIVE-ENERGY RECTO-URETHRAL FISTULAS IN THE PROSTATE CANCER SURVIVOR 2014
  • 1057 WHAT IS THE ANTIBIOTIC OF CHOICE FOR OBSTRUCTING STONE PATIENTS WITH SEPSIS? A CONDITION-SPECIFIC ANTIBIOGRAM 2013
  • 1497 OVERSTAGING HIGH-RISK PROSTATE CANCER MAY LEAD TO OVERTREATMENT: RESULTS FROM THE SEARCH DATABASE 2013
  • 1521 EXERCISE PROTECTS AGAINST SEXUAL DYSFUNCTION IN A COHORT OF MIDDLE-AGED MEN 2013
  • 1799 RADIATION EXPOSURE FROM RENAL MASS PROTOCOL CT: WHAT IS THE IMPACT OF BODY HABITUS? 2013
  • 2076 SPECIFIC ORGAN DOSES UTILIZING A NEW TECHNIQUE FOR IMAGING NEPHROLITHIASIS: DIGITAL TOMOSYNTHESIS 2013
  • 2079 ENERGY AND PULSE REPETITION FREQUENCY DEPENDENT TISSUE INJURY PRODUCED BY A MODIFIED ACOUSTIC LENS FOR ELECTROMAGNETIC LITHOTRIPTERS 2013
  • 2304 IN VIVO STONE COMMINUTION PRODUCED BY A MODIFIED ACOUSTIC LENS FOR ELECTROMAGNETIC LITHOTRIPTERS 2013
  • 316 DECREASED MITOCHONDRIAL AND INSULIN PATHWAY GENE EXPRESSION SIGNAL IN PROSTATE CANCER XENOGRAFT MOUSE MODEL WITH VARYING DIETARY FAT SOURCES 2013
  • 391 MULTICENTER EVALUATION OF THE ROLE OF UROVYSION FISH ASSAY IN SURVEILLANCE OF PATIENTS WITH BLADDER CANCER: DOES FISH POSITIVITY ANTICIPATE RECURRENCE? 2013
  • 977 GENOMIC STUDY OF PROSTATE CANCER DISPARITIES BETWEEN AFRICAN AMERICAN AND CAUCASIAN AMERICAN POPULATIONS 2013
  • 1114 ROBOTIC PARTIAL NEPHRECTOMY VERSUS LAPAROSCOPIC CRYOABLATION FOR THE SMALL RENAL MASS 2012
  • 1173 OUTCOMES OF METALLIC RESONANCE® STENTS IN MALIGNANT URETERAL OBSTRUCTION 2012
  • 1322 THE EFFECT OF POMEGRANATE EXTRACT DOSE ON PROSTATE CANCER GROWTH IN A CARBOHYDRATE RESTRICTED MOUSE XENOGRAFT MODEL 2012
  • 1647 STRIKING REDUCTION IN NEUROGENIC BLADDER DYSFUNCTION FOLLOWING REACTIVE OXYGEN SPECIES SCAVENGING IN THE LUMBOSACRAL SPINAL CORDS OF CHRONIC SPINAL CORD INJURED RATS 2012
  • 2080 ASSESSING THE EFFECTS OF RESPIRATORY MOTION ON STONE COMMINUTION DURING SHOCK WAVE LITHOTRIPSY (SWL) IN AN IN VITRO MODEL 2012
  • 219 DIFFERENTIAL EFFECT OF CALORIC AND CARBOHYDRATE RESTRICTION ON PROSTATE TUMOR CANCER GROWTH AND GENE EXPRESSION IN A XENOGRAFT MODEL 2012
  • 225 THE EFFECTS OF CHOLESTEROL TREATMENT DRUGS ALONE AND IN COMBINATION ON PROSTATE TUMOR XENOGRAFT GROWTH 2012
  • 2296 ORGAN SPECIFIC RADIATION DOSE AND EFFECTIVE DOSE FOR RENAL STONE PROTOCOL COMPUTERIZED TOMOGRAPHY (CT) 2012
  • 270 DRAMATIC ENHANCEMENT OF ANTIMUSCARINIC RESISTANT, HIGH AMPLITUDE NONVOIDING CONTRACTIONS BY INHIBITION OF THE SYMPATHETIC NERVOUS SYSTEM 2012
  • 997 DELAYED RADICAL PROSTATECTOMY IN GLEASON 7 PROSTATE CANCER DECREASES TIME TO BIOCHEMICAL RECURRENCE: RESULTS FROM THE SEARCH DATABASE 2012
  • 1204 HEIGHT AND THE RISK FOR AGGRESSIVE PROSTATE CANCER AT THE TIME OF BIOPSY–RESULTS FROM THE DUKE PROSTATE CENTER DATABASE 2011
  • 1437 EPIDEMIOLOGY AND VARIATION IN MANAGEMENT OF IATROGENIC BLOODSTREAM INFECTIONS FOLLOWING TRANSRECTAL PROSTATE BIOPSY PROCEDURES 2011
  • 1552 IN-VITRO ASSESSMENT OF TIP DYNAMICS IN A NEW PORTABLE BALLISTIC LITHOTRIPTER 2011
  • 1613 GENETIC VARIATION IN OBESITY-RELATED GENES ADBR2, ADBR3, GHRL, HSD11B1, AND SHC1 AND RISK OF PROSTATE CANCER: A VA CASE-CONTROL STUDY 2011
  • 162 SALVAGE RADICAL PROSTATECTOMY AFTER RADIATION THERAPY 2011
  • 2029 SHOULD A DIGITAL RECTAL EXAMINATION BE OPTIONAL FOR EARLY DETECTION OF PROSTATE CANCER IN OBESE MEN? 2011
  • 2035 FAMILY HISTORY OF PROSTATE CANCER DOES NOT INCREASE THE RISK OF DETECTION OF PROSTATE CANCER NOR HIGH GRADE DISEASE IN MEN UNDERGOING INITIAL PROSTATE BIOPSY 2011
  • 2156 OPTIMIZATION OF TREATMENT STRATEGY EMPLOYED DURING SWL TO MAXIMIZE STONE FRAGMENTATION EFFICIENCY 2011
  • 2227 IMAGING NEPHROLITHIASIS: AN PHANTOM MODEL COMPARING DIGITAL TOMOSYNTHESIS TO NON-CONTRAST CT 2011
  • 335 DIABETES MELLITUS AND THE RISK OF HIGH-GRADE PROSTATE CANCER: RESULTS FROM THE DUKE PROSTATE CENTER 2011
  • 396 PRESENCE OF GRP78 ON THE CELL SURFACE OF KIDNEY CANCER CELLS CORRELATES WITH INCREASED ANTI-GRP78 AUTOANTIBODY TITRES IN KIDNEY CANCER PATIENTS- A POTENTIAL NOVEL DIAGNOSTIC MARKER 2011
  • 463 THE ASSOCIATION BETWEEN ANDROGEN DEPRIVATION AND CARDIOVASCULAR EVENTS IN A POPULATION BASED COHORT WITH LONG TERM FOLLOW-UP 2011
  • 468 SECONDARY BLADDER CANCER AFTER RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER 2011
  • 586 COMPARING RADIATION EXPOSURE OF TESTICULAR CANCER MANAGEMENT STRATEGIES 2011
  • 595 LICHEN SCLEROSUS IN MEN IS ASSOCIATED WITH DIABETES AND CORONARY ARTERY DISEASE AND SMOKING 2011
  • 605 COMBINATION OF ADH GENE POLYMORPHISM AND ALCOHOL CONSUMPTION CONSTITUTES A NOVEL PROSTATE CANCER RISK FACTOR IN AFRICAN-AMERICAN MEN 2011
  • 909 INDUCTION OF RADIATION-INDUCED ERECTILE DYSFUNCTION OF RAT AFTER PROSTATE-CONFINED MODERN RADIOTHERAPY 2011
  • 967 C-INDEX ASSOCIATES WITH FUNCTIONAL OUTCOMES AFTER LAPAROSCOPIC PARTIAL NEPHRECTOMY 2011
  • IMPACT OF EXTENDED (E) VERSUS STANDARD LYMPH NODE DISSECTION (SLND) ON POST-CYSTECTOMY SURVIVAL (PCS) AMONG PATIENTS WITH LN-NEGATIVE UROTHELIAL BLADDER CANCER (UBC) 2011
  • 141 STAGE MIGRATION IN PROSTATE CANCER AT RADICAL PROSTATECTOMY DURING THE PSA ERA IS ASSOCIATED WITH RELATIVELY CONSTANT GLEASON SCORE 2010
  • 1437 LOW-CARBOHYDRATE DIETS AND PROSTATE CANCER GROWTH: HOW LOW IS “LOW ENOUGH”? 2010
  • 1488 SURGICAL TREATMENT OF BILATERAL SYNCHRONOUS KIDNEY TUMORS: LONG-TERM FUNCTIONAL AND ONCOLOGICAL OUTCOMES 2010
  • 2008 IDENTIFICATION OF VARIABLES ASSOCIATED WITH INCREASED PAIN DURING TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY 2010
  • 40 URETHROPLASTY FOR RADIOTHERAPY-INDUCED BULBOMEMBRANOUS STRICTURES: A MULTI-INSTITUTIONAL EXPERIENCE 2010
  • 650 PREDICTING ERECTILE DYSFUNCTION FOLLOWING SURGICAL CORRECTION OF PEYRONIE'S DISEASE WITHOUT INFLATABLE PENILE PROSTHESIS PLACEMENT: VASCULAR ASSESSMENT AND PREOPERATIVE RISK FACTORS 2010
  • 89 EFFECT OF VOLUNTARY WHEEL RUNNING ON GROWTH OF PROSTATE CANCER IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT MOUSE MODELS 2010
  • SIMVASTATIN INHIBITS THE GROWTH OF ANDROGEN-SENSITIVE AND ANDROGEN-INDEPENDENT CELLS IN VITRO 2010
  • THE USE OF SIMVASTATIN AND EZETIMIBE AS NOVEL THERAPEUTICS FOR PROSTATE CANCER IN A XENOGRAFT MODEL 2010
  • 5-YEAR RESULTS OF A MULTI-CENTER STUDY OF COOLED THERMOTHERAPY FOR BENIGN PROSTATIC HYPERPLASIA 2009
  • A MULTI-INSTITUTIONAL COMPARISON OF ROBOTIC PARTIAL NEPHRECTOMY AND LAPAROSCOPIC PARTIAL NEPHRECTOMY 2009
  • A PROSPECTIVE RANDOMIZED EVALUATION OF LAPAROSCOPIC DOPPLER TECHNOLOGY FOR HILAR DISSECTION DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY 2009
  • BODY MASS INDEX AND PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY 2009
  • COMPLEX ROBOTIC PARTIAL NEPHRECTOMY: DEALING WITH DILEMMAS 2009
  • DOES PATHOLOGICAL GLEASON SCORE RE-REVIEW BY A MODERN PATHOLOGIST IMPROVE RISK STRATIFICATION RELATIVE TO HISTORICAL GLEASON SCORE? 2009
  • DOES RISING URINE PH INCREASE THE STONE FORMATION RATE? 2009
  • DUAL ENERGY COMPUTED TOMOGRAPHY WITH ADVANCED POST-IMAGE ACQUISITION DATA PROCESSING: IMPROVED IN VITRO AND IN VIVO DETERMINATION OF URINARY STONE COMPOSITION 2009
  • EFFECTS OF EXERCISE ON PROSTATE CANCER GROWTH IN A MOUSE MODEL 2009
  • INFECTION RETARDANT COATED VERSUS NON-COATED PENILE PROSTHESIS CULTURES DURING REVISION SURGERY: A MULTICENTER STUDY 2009
  • PHASE I TRIAL OF PROSTATECTOMY AFTER PLANNED PRE-OPERATIVE RADIOTHERAPY FOR HIGH RISK LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS 2009
  • PSA DENSITY PREDICTS PATHOLOGIC UPSTAGING AFTER RADICAL PROSTATECTOMY 2009
  • RECALIBRATION AND EXTERNAL VALIDATION OF AN EXISTING NOMOGRAM TO PREDICT AGGRESSIVE RECURRENCES AFTER RADICAL PROSTATECTOMY (RP) 2009
  • THE FIRST DRUG ELUTING URETERAL STENT: A PROSPECTIVE, RANDOMIZED, MULTICENTER CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFECTIVENESS OF A KETOROLAC-LOADED URETERAL STENT 2009
  • TUBELESS-STENTLESS PERCUTANEOUS NEPHROLITHOTOMY: A FURTHER ADVANCE IN PERCUTANEOUS URINARY STONE MANAGEMENT 2009
  • VARIATION IN IMAGING UTILIZATION FOR URINARY LITHIASIS IN THE UNITED STATES 2009
  • COMPARISON OF COMMINUTION AND STONE CLEARANCE BETWEEN INTRACORPOREAL LITHOTRIPTERS 2008
  • CONTINUING RESULTS OF A MULTI-CENTER TRIAL OF A NEW GENERATION COOLED TRANS URETHRAL MICROWAVE THERAPY FOR BENIGN PROSTATIC HYPERPLASIA 2008
  • DOES PRACTICE REFLECT THE EVIDENCE? LYMPH NODE DISSECTION WITH RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE 2008
  • DYNAMIC SCREENING DETECTS PROSTATE CANCER (PC) EARLIER AND WOULD LEAD TO IMRPROVED CANCER CONTROL: RESULTS FROM THE DUKE PROSTATE CENTER AND THE SEARCH DATABASE 2008
  • DYNAMIC SCREENING FOR PROSTATE CANCER IMPROVES AUCs RELATIVE TO STATIC SCREENING USING A SINGLE PSA THRESHOLD – RESULTS FROM THE DUKE PROSTATE CENTER 2008
  • EFFECTS OF AGE, HEALTH-RELATED QUALITY OF LIFE, AND EDUCATION LEVEL ON MANAGEMENT AFTER BIOCHEMICAL FAILURE WITH WATCHFUL WAITING VERSUS HORMONAL THERAPY IN MEN WITH PROSTATE CANCER: RESULTS FROM THE COMPARE REGISTRY 2008
  • Evidence based medicine training in residency: A survey of urology program directors 2008
  • IMPROVEMENT IN STONE COMMINUTION OF MODERN ELECTROMAGNETIC LITHOTRIPTERS BY TANDEM PULSE SEQUENCE 2008
  • INTEROBSERVER AGREEMENT IN THE APPLICATION OF LEVELS OF EVIDENCE RATINGS TO THE UROLOGICAL LITERATURE 2008
  • IS PSA A POOR PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL FAILURE FOLLOWING RADICAL PROSTATECTOMY IN OBESE MEN? 2008
  • MANAGEMENT OF RECURRENT PROSTATE CANCER AFTER RADIOTHERAPY: RESULTS FROM CALGB 9687, A CONTEMPORARY PROSPECTIVE MULTI-INSTITUTIONAL SALVAGE RADICAL PROSTATECTOMY SERIES 2008
  • NEOADJUVANT DOCETAXEL WITH SUBSEQUENT CYOABLATION OF AN AGGRESSIVE RM-9 MURINE PROSTATE CANCER MODEL IS ASSOCIATED WITH DECREASE IN INTERSTITIAL FLUID PRESSURE AND IMPROVEMENT OF OXYGENATION 2008
  • NEW STONE HOLDER MIMICS IN-VIVO STONE MOVEMENT FOR IN-VITRO CHARACTERIZATION OF SHOCKWAVE LITHOTRIPTERS 2008
  • OBESE MEN HAVE LARGER AND HIGHER-GRADE TUMORS: AN ANALYSIS OF THE DUKE PROSTATE CENTER DATABASE 2008
  • OBESITY AS A PREDICTOR OF ADVERSE OUTCOME ACROSS BLACK AND WHITE RACE: RESULTS FROM THE SEARCH AND DUKE PROSTATE CENTER DATABASES 2008
  • OLDER MEN ASSOCIATED WITH ADVANCED DISEASE AND POOR OUTCOME: AN ANALYSIS OF 14601 PROSTATE CANCER MEN IN DUKE PROSTATE CENTER 2008
  • PENILE PROSTHESIS PLACEMENT IN MEN AFTER TRANSCORPORAL ARTIFICIAL URINARY SPHINCTER IMPLANTATION 2008
  • PRACTICE PATTERNS IN SURGICAL THERAPY FOR URINARY LITHIASIS 2008
  • PRE-TREATMENT FACTORS PREDICTIVE OF POSITIVE SURGICAL MARGIN IN CONTEMPORARY RADICAL PROSTATECTOMIES 2008
  • Perceptions and competence in evidence-based medicine: Results of the 2006 survey of AUA members 2008
  • RACE AND PROSTATE WEIGHT AS INDEPENDENT PREDICTORS FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY 2008
  • RADIATION EXPOSURE IN THE ACUTE AND SHORT-TERM MANAGEMENT OF UROLITHIASIS: A MULTI-INSTITUTIONAL REVIEW 2008
  • RANDOMIZED CONTROLLED TRIAL COMPARING A DUAL PROBE ULTRASONIC LITHOTRITE TO A SINGLE PROBLE LITHOTRITE FOR PERCUTANEOUS NEPHROLITHOTOMY (PNL) 2008
  • ROBOTIC RECONSTRUCTION OF THE URINARY TRACT 2008
  • ROBOTIC-ASSISTED URETERAL RE-IMPLANT AND PSOAS HITCH IN THE TREATMENT OF DISTAL URETERAL STRICTURE 2008
  • SMALL PROSTATE SIZE PREDICTS BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY 2008
  • SMALLER FOCAL SIZE DOES NOT IMPROVE STONE COMMINUTION – IN VITRO AND IN VIVO COMPARISON OF ORIGINAL AND MODIFIED REFLECTOR FOR HM3 2008
  • THE ASSOCIATION BETWEEN CHOLESTEROL AND PSA 2008
  • THE IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY FOR PATIENTS WITH PATHOLOGICAL T3b PROSTATE CANCER 2008
  • THE INFLUENCE OF STATIN MEDICATIONS ON PSA VELOCITY IN HEALTHY MEN 2008
  • UTILIZATION OF LYMPH NODE DISSECTION WITH RADICAL PROSTATECTOMY IN THE UNITED STATES 2008
  • WHAT ARE THE DIFFERENCES BETWEEN ROBOTIC DISMEMBERED PYELOPLASTY FOR PRIMARY OR SECONDARY URETEROPELVIC JUNCTION OBSTRUCTION? 2008
  • Stimulation of the tachykinin NK1 receptor is required for the spinal micturition reflex in spinal cord injured (SCI) but not spinally intact rats 2008
  • 1027: Tumor Percentage of Prostatectomy Specimens is an Independent Risk Factor for Biochemical Recurrence and Negative Clinicopathological Variables 2007
  • 1066: A Thank You to Syphilis for Modern Urography 2007
  • 1231: Complications of Laparoscopic Surgery for Urological Cancer 2007
  • 1364: Long Term Potassium Citrate Therapy does Impact Urine pH 2007
  • 1366: Correlation between Stone Formation and Weight Loss After Roux-en-Y Gastric Bypass 2007
  • 1403: “Insignificant” Prostate Cancer Treated by Radical Retropubic Prostatectomy has a Risk of Progression Similar to Low-Risk “Significant” Cancer 2007
  • 1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men? 2007
  • 1423: The Impact of Gleason Score on the Predictive Value of PSA Doubling Time 2007
  • 1444: Efficacy of Intravesical Ropivacaine Injection on Urinary Symptoms following Ureteral Stenting: A Randomized, Controlled Study 2007
  • 1448: A Novel Radial-Dilating Balloon-Expandable Ureteral Access Sheath: The Initial Human Experience 2007
  • 1496: Does a 5-Day Preoperative Topical Antimicrobial Scrub Reduce Positive Culture Rates in Men Undergoing Artificial Urinary Sphincter Placement? 2007
  • 15: Levels of Evidence in the Urology Literature 2007
  • 1635: Assessment of Citrate Concentrations in Beverages Using 1H NMR 2007
  • 1884: Up to 53.8% Discrepancy between Diagnostic and Pathological Gleason Scores in 2963 Prostate Cancer Patients: The Predictive Value of Age and Prostate Size 2007
  • 1948: Saturation Biopsy: Does it Really Detect More Cancer? 2007
  • 207: Management of Prostate-specific Antigen (PSA) Recurrence after Initial Definitive Local Therapy for Prostate Cancer: Updated Results from the Compare Registry 2007
  • 255: Rescue of Urethral Relaxation By B3-Adrenoceptors in Diabetic Female Rats Following Loss of Nitrergic Mechanisms 2007
  • 281: The Role of the Type III TGF-BETA Receptor in Prostate Cancer 2007
  • 439: Evaluating the Evidence: Statistical Analysis in Randomized Controlled Trials in the Urology Literature 2007
  • 440: Barriers to the Practice of Evidence Based Urology in the United States 2007
  • 455: Racial Disparities Remain in Prostate Cancer - An Analysis on 10530 Men Diagnosed During PSA Era 2007
  • 518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy? 2007
  • 519: Bladder and Ureteral Anomalies do not Reduce the Efficacy of Dextranomerihyaluronic Acid for Vesicoureteral Reflux 2007
  • 601: Timing of Androgen Deprivation Therapy and Its Impact on Cancer-Specific Survival after Radical Prostatectomy: A Matched-Cohort Analysis 2007
  • 618: Intraoperative Infrared Imaging to Assess Segmental Renal Perfusion: A Model for Renal Transplantation and Nephron Sparing Surgery 2007
  • 879: PD-L1 (B7-H1) Expression by Urothelial Carcinoma of the Bladder and BCG-Induced Granulomata: Associations with Localized Stage Progression 2007
  • 920: Pediatric Renal Cell Carcinoma: An Aggressive Tumor with Biologic Features Distinct From Its Adult Counterpart 2007
  • V1053: Digital Video Ureteroscopy: The New Paradigm 2007
  • V1825: The Escape™ Nitinol Retrieval Basket: A Novel Approach to Endoscopic Urinary Calculus Fragmentation 2007
  • V1827: Demonstration of a Novel Radial-Dilating Ballon-Expandable Ureteral Access Sheath 2007
  • 1038: Lemonade-Based Dietary Manipulation in Patients with Hypocitraturic Nephrolithiasis 2006
  • 1107: Predictors of Survival for Carcinomas of the Upper Urinary Tract 2006
  • 1121: The Relationship between Renal Angiomyolipoma, Renal Cell Carcinoma and Tuberous Sclerosis 2006
  • 1162: Can Unilateral Prostate Cancer Be Reliably Predicted Based Upon Biopsy Features? 2006
  • 1530: Nephrolithiasis in Identical Twins - The Impact of Nature vs. Nurture 2006
  • 1539: Comparison of Light Spot Hydrophone (LSHD) and Fiber Optic Probe Hydrophone (FOPH) for Lithotripter Field Characterization 2006
  • 1596: Choices for Definitive Treatment of Early-Stage Prostate Cancer: Results from the Compare Registry 2006
  • 1665: Practice Patterns of Ureteral Stenting following Routine Ureteroscopic Stone Surgery: A Survey of Practicing Urologists 2006
  • 1709: Changing Practice Patterns for the Surgical Management of Renal Calculi 2006
  • 17: Utilization and Outcomes of Intracytoplasmic Sperm Injection for Non-Male Factor Infertility 2006
  • 205: Variations in Prostate Cancer Care According to Race, Geographic Region, and Literacy: Initial Findings from the Compare Registry 2006
  • 220: Local Cost Structures and the Economics of Robot Assisted Radical Prostatectomy 2006
  • 262: KI-67: A Potential Prognostic Biomarker for PSA Recurrence? 2006
  • 552: Forced Versus Minimal Intravenous Hydration in the Management of Acute Renal Colic: A Prospective, Randomized Trial 2006
  • 646: 25-Year Outcomes of Radical Prostatectomy for the Treatment of All Stages of Non-Metastatic Prostate Cancer 2006
  • Evaluating the evidence: Randomized controlled trial reporting in the urologic literature 2006
  • Evaluating the evidence: Statistical methods in the urology literature 2006
  • 1098: Location and Etiology of Flexible and Semi-Rigid Ureteroscope Damage 2005
  • 1099: Changing Gender Prevalence of Nephrolithiasis 2005
  • 1108: Treatment Strategy Improves the in Vivo Stone Comminution Efficiency and Reduces Renal Tissue Injury During Shock Wave Lithotripsy 2005
  • 1173: A Controlled Survival Study Evaluating the Effects of Tisseel, or a Combination of Floseal and Tisseel, on Both Major Vascular Injury and Major Collecting System Injury During Partial Nephrectomy in a Porcine Model 2005
  • 1209: Diabetic Urethropathy Compounds the Effects of Diabetic Cystopathy: An Intensive in Vivo Study in the Rat 2005
  • 1385: Significant Variation in BPH-Surgical Rates Explained by Medical Therapy Rates, Health Resources and Sociodemograpidc Factors 2005
  • 1553: Intermediate Results of a Multi-Center Trial of a New Generation Cooled TUMT for BPH 2005
  • 1581: Digital Video Ureteroscope: A New Paradigm in Ureteroscopy 2005
  • 1683: A Prospective Randomized Clinical Trial Comparing Levels of Symptoms and Discomfort Associated with Two Investigational and Two Currently Marketed Ureteral Stents 2005
  • 195: Radical Perineal Prostatectomy for the Treatment of Localized Prostate Cancer in Obese and non-obese Patients: A Matched Control Study 2005
  • 235: Evaluation of Serum Seldi-Tof Proteomic Information and Tumor Volume in Prostate Cancer Patients 2005
  • 518: A Comparison of Renal Function Following Hand Assisted Laparoscopic Nephrectomy and open Nephrectomy in Patients with a Normal Contralateral Kidney 2005
  • Significant variation in medical therapy treatment rates explained by local market factors 2005
  • 1115: The Effect of Treatment Strategy on Stone Comminution Efficiency in Shock Wave Lithotripsy 2004
  • 1116: Improved Stone Comminution and Simultaneously Reduced Tissue Injury with an Upgraded Electrohydraulic Lithotripter: in Vivo Studies 2004
  • 1120: Citrate and Vitamin E Blunt the SWL-Induced Free Radical Surge in an In-Vitro MDCK Cell Culture Model 2004
  • 1143: Ethnic Background has Minimal Impact on the Etiology of Nephrolithiasis 2004
  • 1146: Appropriate Medical Treatment After Percutaneous Nephrolithotomy can Control Active Stone Disease in the Presence of Residual Calculi 2004
  • 1482: Hand Assisted Laparoscopic Nephrectomy: Hand Port and Radially Dilating Trocar Site Complications 2004
  • 1530: Results of A Multi-Center Trial of A New Generation Cooled Tumt for BPH 2004
  • 1666: Serum Proteomic Profiling Using Seldi-Tof for Prostate Cancer Diagnosis 2004
  • 1668: Insulin-Like Growth Factor Binding Protein 2 is an Independant Predictor of Prostate Cancer Survival 2004
  • 1678: In Vitro Comparison of two Commercially Available Holmium:Yag Laser Fibers 2004
  • 1727: Effects of Alpha-1 Adrenergic Receptor Subtype· Selective Antagonists on Lower Urinary Tract Function in RATS with Bladder Outlet Obstruction 2004
  • 1876: Ureteroscopic Management of Symptomatic Renal Calculi: Do Ureteral Access Sheaths Improve Stone Free Rates? 2004
  • 1890: The Ureteral Access Sheath Provides Protection Against Elevated Intra-Renal Pressures Generated During Routine Flexible Ureteroscopic Stone Manipulation 2004
  • 1896: Ureteroscopic Management of Calculi in Anomalous Kidneys 2004
  • 255: Risk Factors for Bladder Cancer Recurrence Following Urothelial Carcinoma of the Upper Urinary Tract 2004
  • 376: Internet-Based Multi-Institutional Clinical Research: A Convenient and Secure Option 2004
  • 459: Supplement -Use Among Prostate Cancer Survivors 2004
  • 50: Bacteriologic Profile of Studer Orthotopic Neobladders and the Risk of Urinary Tract Infection 2004
  • 536: Dramatic Reversal of Detrusor-Sphincter Dyssynergia in the Rat By a 5-HT1A Serotonin Receptor Agonist 2004
  • 56: Utility of Routine Urine Cytology in the Followup of Patients with Studer Orthotopic Neobladders 2004
  • 8: The Use of Stone Cone Minimizes Stone Migration During Percutaneous Nephrolithotomy 2004
  • Hand assisted laparoscopic heminephrectomy in horseshoe kidney 2004
  • V220: Hand Assisted Laparoscopic Partial Nephrectomy Using a Saline-Cooled Radiofrequency Device without Hilar Vascular Control 2004
  • An excitatory urethra-to-bladder reflex in humans 2003
  • Clinical efficacy of a combination pneumatic and ultrasonic lithotrite: The lithoclast ultra 2003
  • Diagnosis and monitoring of bladder cancer tumors using ImmunoCyt/uCyt plus in routine clinical practice 2003
  • Diagnostic potential of serum proteomic patterns in prostate cancer 2003
  • Impact of medical therapy on the management of nephrolithiasis in obese patients 2003
  • Longitudinal assessment of quality of life and disease uncertainty in patients undergoing radical prostatectomy and their spouses/partners 2003
  • Neoinfundibulotomy for the management of symptomatic calyceal diverticula 2003
  • Pain after percutaneous nephrolithotomy: Impact of nephrostomy tube size 2003
  • Percutaneous management of calculi within horseshoe kidneys 2003
  • The role of stress waves and cavitation in stone comminution in shock wave lithotripsy 2003
  • Durability of the medical management of cystinuria 2002
  • Dynamics of lithotripter shock-wave-induced bubble oscillation in constrained media and mechanisms of vessel rupture during SWL 2002
  • Evaluation of a dissolvable ureteral drainage stent in a swine model 2002
  • Evaluation of synchronous twin pulse technology for shock wave lithotripsy: In vitro evaluation of optimal parameters 2002
  • In vitro comparison of the new Lithoclast Ultra with standard ultrasonic and pneumatic lithotrites. 2002
  • Laser Doppler flowmetric determination of ureteral blood flow during ureteral access sheath placement 2002
  • Neoinfundibulotomy assists in the management of symptomatic calyceal diverticula 2002
  • Routine post-operative imaging is important following ureteroscopic stone manipulation 2002
  • Safety and efficacy of holmium : YAG laser lithotripsy in patients with bleeding diatheses 2002
  • Suppression of large intraluminal bubble expansion during SWL 2002
  • Temporary ureteral drainage stent (TUDS) post uncomplicated ureteroscopy: Results from a preliminary phase II clinical trial 2002
  • 12 months follow-up of a randomized, blinded study comparing microwave thermotherapy (Dornier Urowave (TM)) with a sham procedure in patients with clinical benign prostatic hyperplasia (BPH). 1998
  • An in vitro study of stone fragility comparing natural calcium and cystine stones with artificial stone phantoms. 1998
  • In vitro stone fragmentation analysis of compacts versus HM-3 lithotripters 1998
  • Influence of chemolysis on comminution of artificial stones. 1998
  • Incontinent ileo-vesicostomy urinary diversion in the treatment of lower urinary tract dysfunction. 1994
  • DISCUSSION 1994
  • Discussion 1994
  • Discussion 1994
  • Discussion 1994
  • Discussion 1994
  • The mediator of human corpus cavernosum relaxation is nitric oxide 1991
  • Metabolic Implications of Continent Urinary Diversions 1987
  • Potassium Citrate Therapy VS Sodium Alkali in Renal Tubular Acidosis 1987
  • SIMPLIFIED APPROACH TO THE MEDICAL EVALUATION OF NEPHROLITHIASIS 1986